STOCK TITAN

Axe Compute earns $11.5M in Q3 on $7.24M revenue

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

AXE Compute Inc. (AGPU) reported third-quarter revenue of $7,243,043 and net income of $11,503,607, compared with $0 revenue and a $77,651,844 net loss in 2025. For the first nine months, revenue was $10,457,323 and net loss was $13,411,219, versus an $82,165,179 loss a year earlier. Third-quarter results included $10,477,971 of gains on digital assets.

On September 30, the company acquired the SPV holding a cluster of 288 servers with 2,304 GPUs in an asset acquisition with total recorded asset cost of $124.4 million. At quarter-end, property and equipment, net, was $366,739,691, all construction in progress and none placed in service. The company also sold Helomics on September 11, receiving DataMeds shares and a convertible note, and classified the business as discontinued operations.

Customer prepayments brought contract liabilities and remaining performance obligations to $569,338,973, with revenue scheduled through 2029. Separately, signed compute leases not yet commenced carry $407.4 million in future payments and are expected to commence in 2026 and 2027.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

How the balance works

Positive

  • Moderate pointThird-quarter net income was $11,503,607, versus a $77,651,844 loss in 2025.
  • Minor pointNine-month net loss was $13,411,219, versus $82,165,179 in 2025.

Negative

  • None.

Filing Explained

At September 30, 2026, roughly $83 million remained available for future ATM sales; using it would create further share issuance and ownership dilution.

At September 30, 2026, Axe Compute had 13,634,097 common shares outstanding, compared with 4,083,173 at December 31, 2025.

It also had 7,736,379 pre-funded warrants outstanding, all vested and exercisable at one cent per share with no expiration date. If exercised, those warrants would add common shares and reduce existing holders’ percentage ownership.

The company’s ATM agreement had up to $100 million of aggregate sales capacity, with about $83 million still available at September 30, 2026. It had already sold 1,063,864 shares through that program in April 2026, netting about $10.3 million. An at-the-market program permits gradual sales of new shares at prevailing prices; the remaining amount is capacity for future sales, not shares already issued.

Third-quarter revenue $7,243,043 Three months ended September 30, 2026; revenue was $0 in 2025.
Third-quarter net income $11,503,607 Three months ended September 30, 2026; net loss was $77,651,844 in 2025.
Nine-month revenue $10,457,323 Nine months ended September 30, 2026; revenue was $0 in 2025.
Nine-month net loss $13,411,219 loss Nine months ended September 30, 2026; net loss was $82,165,179 in 2025.
Contract liabilities $569,338,973 As of September 30, 2026; comprised of customer prepayments.
Property and equipment, net $366,739,691 As of September 30, 2026; the balance was construction in progress and not yet placed in service.
Asset acquisition cost $124.4 million Recorded for the assets acquired through the SPV on September 30, 2026.
Future lease payments $407.4 million Signed compute leases that had not commenced as of September 30, 2026.
take-or-pay provisions financial
"including take-or-pay provisions intended to provide income visibility throughout the contract term"
A take-or-pay provision is a contract clause that requires one party, typically a buyer, to either take a minimum amount of goods or services from a supplier or pay a fee for the shortfall. For investors, these clauses create predictable revenue for the seller and potential cash obligations or liability for the buyer, similar to a subscription where you must pay whether you use the service or not, which affects cash flow, profitability and risk assessment.
remaining performance obligations financial
"As of September 30, 2026, the Company had $569.3 million of remaining performance obligations."
Remaining performance obligations are the work a company still needs to complete for its customers, like finishing a service or delivering a product. It’s important because it shows how much future income the company has coming in from current agreements, giving a clearer picture of its ongoing business.
contract liabilities financial
"The Company’s contract liabilities are comprised of prepayments received from compute services customers."
Contract liabilities are amounts a company has been paid in advance for goods or services it still owes to customers — think of them like gift cards or prepaid subscriptions the company must fulfill later. For investors, they show promised future work or deliveries that will turn into revenue over time, reveal cash already collected, and help assess whether a firm has a backlog of obligations that could affect future earnings and cash flow.
construction in progress technical
"the entirety of the technology equipment balance represents construction in progress"
Construction in progress is an accounting item on a company's balance sheet that records money spent on buildings, equipment or other long-term projects that are not yet finished and ready for use. Investors watch it because it shows where a company is committing capital now for future operations or revenue; rising balances can signal growth plans or costly delays, while completed projects will later affect depreciation and earnings.
Level 3 measurement financial
"the fair value of the note is a Level 3 measurement"
embedded derivative financial
"embedded derivative related to the digital asset receivable"
An embedded derivative is a built-in feature inside a contract—like a bond, loan, or lease—that causes part of the payout to change based on something else, such as a stock price, interest rate, or commodity price. It matters to investors because that hidden feature can add separate risk and volatility to a security’s value and accounting treatment, like finding a removable engine in a car that changes how fast it can go and how much it’s worth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much revenue and net income did AGPU report in Q3 2026?

AGPU reported revenue of $7,243,043 and net income of $11,503,607 for the three months ended September 30, 2026. In the year-earlier quarter, revenue was $0 and net loss was $77,651,844. The quarter also included $10,477,971 in gains on digital assets.

What were the terms of AGPU's Duos Cluster acquisition?

On September 30, 2026, Axe Compute acquired 100% of the SPV that held 288 servers containing 2,304 GPUs. Consideration included $87.8 million in cash to satisfy the SPV's outstanding borrowings and related obligations plus closing fees, and a $42.9 million deferred purchase price payable in monthly installments of $715,000 over an initial 60-month term. Unpaid amounts are due earlier of September 30, 2027, or financing secured by the Cluster.

How much remaining performance obligation did AGPU report?

AGPU reported $569,338,973 in remaining performance obligations as of September 30, 2026. It expected to recognize $8,104,000 in the remaining three months of 2026, $129,093,077 in 2027, $127,220,420 in 2028, and $304,921,476 in 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Q3 2026 --12-31 false 0001446159 5 1 1 3 0 0 10 3 0 0 10 10 4 2 http://fasb.org/us-gaap/2026#OperatingLeaseLeaseNotYetCommencedMember 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0.25 0 http://www.precisiontherapeutics.com/20260930#BirminghamLaboratoryAndEaganBusinessMember http://www.precisiontherapeutics.com/20260930#HelomicsMember 15 0 0.01 0.01 0.01 0.01 00014461592026-01-012026-09-30 thunderdome:item iso4217:USD 0001446159us-gaap:SubsequentEventMemberagpu:MultiyearStrategicPartnershipWithPenguinSolutionsMember2026-10-31 utr:Y 0001446159us-gaap:SubsequentEventMemberagpu:MultiyearStrategicPartnershipWithPenguinSolutionsMember2026-10-012026-10-31 0001446159agpu:SingleReportableSegmentMember2025-01-012025-09-30 0001446159agpu:SingleReportableSegmentMember2026-01-012026-09-30 0001446159agpu:SingleReportableSegmentMember2025-07-012025-09-30 0001446159agpu:SingleReportableSegmentMember2026-07-012026-09-30 0001446159agpu:SingleReportableSegmentMember2025-12-31 0001446159agpu:SingleReportableSegmentMember2026-09-30 xbrli:pure xbrli:shares 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-01-012025-09-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-01-012026-09-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-07-012025-09-30 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-07-012026-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-01-012025-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-07-012025-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-07-012026-09-30 0001446159us-gaap:WarrantMember2025-01-012025-09-30 0001446159us-gaap:WarrantMember2026-01-012026-09-30 0001446159us-gaap:WarrantMember2025-07-012025-09-30 0001446159us-gaap:WarrantMember2026-07-012026-09-30 0001446159us-gaap:EmployeeStockOptionMember2025-01-012025-09-30 0001446159us-gaap:EmployeeStockOptionMember2026-01-012026-09-30 0001446159us-gaap:EmployeeStockOptionMember2025-07-012025-09-30 0001446159us-gaap:EmployeeStockOptionMember2026-07-012026-09-30 00014461592026-07-012026-09-30 00014461592025-01-012025-09-30 00014461592025-07-012025-09-30 iso4217:USDxbrli:shares 0001446159agpu:PrefundedWarrantsMember2026-09-30 0001446159us-gaap:EmployeeStockOptionMember2026-01-012026-09-30 0001446159us-gaap:EmployeeStockOptionMember2026-09-30 0001446159us-gaap:EmployeeStockOptionMember2025-01-012025-09-30 0001446159us-gaap:EmployeeStockOptionMembersrt:MaximumMember2026-01-012026-09-30 0001446159us-gaap:EmployeeStockOptionMembersrt:MinimumMember2026-01-012026-09-30 00014461592026-09-30 00014461592025-12-31 00014461592025-01-012025-12-31 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2026-01-012026-09-30 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-12-31 0001446159us-gaap:RestrictedStockUnitsRSUMembersrt:ChiefExecutiveOfficerMember2025-12-102025-12-10 0001446159us-gaap:RestrictedStockUnitsRSUMember2025-09-092025-09-09 0001446159agpu:StockWarrantsMember2025-01-012025-09-30 0001446159agpu:StockWarrantsMember2026-01-012026-09-30 0001446159agpu:StockWarrantsMember2026-09-30 0001446159agpu:StockWarrantsMember2026-01-012026-09-30 0001446159agpu:PrefundedWarrantMember2026-09-30 0001446159agpu:PrefundedWarrantMember2026-01-012026-09-30 0001446159agpu:CryptoPIPEWarrantsMember2025-10-07 0001446159agpu:CashPIPESPAMember2025-10-07 0001446159agpu:CashPIPEWarrantsMember2025-10-07 0001446159agpu:CashPIPESPAMember2025-10-072025-10-07 0001446159agpu:SalesAgreementMember2026-09-30 0001446159agpu:SalesAgreementMember2026-05-15 0001446159agpu:SalesAgreementMember2026-01-012026-09-30 0001446159agpu:SalesAgreementMember2024-05-032026-05-13 0001446159agpu:SalesAgreementMember2026-04-012026-04-30 0001446159agpu:SalesAgreementMember2026-04-30 0001446159agpu:SalesAgreementMember2025-10-29 0001446159agpu:SalesAgreementMember2025-09-30 0001446159agpu:SalesAgreementMember2025-06-02 0001446159agpu:SalesAgreementMember2025-05-31 0001446159agpu:SalesAgreementMember2025-04-18 0001446159agpu:SalesAgreementMember2024-05-03 0001446159agpu:InsurancePolicyFinancingMember2025-12-31 0001446159agpu:InsurancePolicyFinancingMember2025-06-30 0001446159agpu:InsurancePolicyFinancingMember2025-06-302025-06-30 0001446159agpu:InsurancePolicyFinancingMember2026-09-30 0001446159agpu:InsurancePolicyFinancingMember2026-06-30 0001446159agpu:InsurancePolicyFinancingMember2026-06-302026-06-30 0001446159srt:MaximumMember2026-09-30 0001446159srt:MinimumMember2026-09-30 0001446159us-gaap:PaymentGuaranteeMember2026-09-30 0001446159agpu:DeferredPurchasePricePayableMember2026-09-30 0001446159agpu:ComputeAgreementsMember2026-09-30 utr:M 0001446159srt:MinimumMemberagpu:ComputeAgreementsMember2026-01-012026-09-30 0001446159us-gaap:PropertyPlantAndEquipmentMember2025-07-012025-09-30 0001446159us-gaap:PropertyPlantAndEquipmentMember2026-07-012026-09-30 0001446159us-gaap:PropertyPlantAndEquipmentMember2025-01-012025-09-30 0001446159us-gaap:PropertyPlantAndEquipmentMember2026-01-012026-09-30 0001446159agpu:DuosEdgeAIGPUaaSLLCMember2026-01-012026-09-30 0001446159agpu:DuosEdgeAIGPUaaSLLCMember2026-07-012026-09-30 0001446159us-gaap:EquipmentMember2026-07-012026-09-30 0001446159us-gaap:TechnologyEquipmentMember2025-12-31 0001446159us-gaap:TechnologyEquipmentMember2026-09-30 0001446159us-gaap:OfficeEquipmentMember2025-12-31 0001446159us-gaap:OfficeEquipmentMember2026-09-30 0001446159us-gaap:PaymentGuaranteeMemberus-gaap:MeasurementInputDefaultRateMember2026-09-30 0001446159us-gaap:PaymentGuaranteeMemberus-gaap:MeasurementInputLossSeverityMember2026-09-30 0001446159us-gaap:PaymentGuaranteeMemberagpu:MeasurementInputGuaranteedFeesMember2026-09-30 0001446159us-gaap:NotesReceivableMember2026-09-30 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-09-30 0001446159us-gaap:NotesReceivableMember2026-07-012026-09-30 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-07-012026-09-30 00014461592026-06-30 0001446159us-gaap:NotesReceivableMember2026-06-30 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-06-30 00014461592026-04-012026-06-30 0001446159us-gaap:NotesReceivableMember2026-04-012026-06-30 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-04-012026-06-30 00014461592026-03-31 0001446159us-gaap:NotesReceivableMember2026-03-31 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-03-31 00014461592026-01-012026-03-31 0001446159us-gaap:NotesReceivableMember2026-01-012026-03-31 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2026-01-012026-03-31 0001446159us-gaap:NotesReceivableMember2025-12-31 0001446159us-gaap:EmbeddedDerivativeFinancialInstrumentsMember2025-12-31 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2025-12-31 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2025-12-31 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MaximumMember2026-09-30 0001446159agpu:AethirATHMemberus-gaap:MeasurementInputDiscountRateMembersrt:MinimumMember2026-09-30 0001446159agpu:ConvertiblePromissoryNoteMember2026-01-012026-09-30 0001446159agpu:ConvertiblePromissoryNoteMember2026-07-012026-09-30 0001446159agpu:ConvertiblePromissoryNoteMemberus-gaap:MeasurementInputPriceVolatilityMember2026-09-30 0001446159agpu:ConvertiblePromissoryNoteMemberagpu:MeasurementInputCreditYieldMember2026-09-30 0001446159agpu:ConvertiblePromissoryNoteMemberus-gaap:MeasurementInputRiskFreeInterestRateMember2026-09-30 0001446159agpu:ConvertiblePromissoryNoteMember2026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-01-012026-09-30 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-07-012026-09-30 0001446159agpu:DataMedsMember2026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-09-112026-09-11 0001446159us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueMeasurementsRecurringMember2025-12-31 0001446159us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001446159us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001446159us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001446159us-gaap:FairValueMeasurementsRecurringMember2026-09-30 0001446159agpu:AethirATHMember2025-01-012025-12-31 0001446159agpu:AethirATHMember2025-12-31 0001446159agpu:AethirATHMember2026-01-012026-09-30 0001446159agpu:AethirATHMember2026-07-012026-09-30 0001446159agpu:AethirATHMember2026-09-30 0001446159agpu:AethirATHMemberagpu:SideLetterAgreementMember2025-10-07 0001446159agpu:AethirFoundationMemberagpu:AethirATHMember2026-09-30 0001446159agpu:AethirFoundationMemberagpu:AethirATHMember2026-01-012026-09-30 0001446159agpu:NonATHMember2026-09-30 0001446159agpu:AethirATHMember2026-06-30 00014461592029-01-012026-09-30 00014461592028-01-012026-09-30 00014461592027-01-012026-09-30 00014461592026-10-012026-09-30 0001446159us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-01-012026-09-30 0001446159us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-01-012026-09-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-01-012026-09-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerBMember2026-07-012026-09-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-01-012026-09-30 0001446159us-gaap:RevenueFromContractWithCustomerMemberus-gaap:CustomerConcentrationRiskMemberagpu:CustomerAMember2026-07-012026-09-30 0001446159agpu:DeRoyalIndustriesIncMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2025-01-012025-09-30 0001446159agpu:DeRoyalIndustriesIncMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2025-07-012025-09-30 0001446159agpu:DeRoyalIndustriesIncMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2025-09-30 0001446159agpu:DeRoyalIndustriesIncMemberus-gaap:DiscontinuedOperationsDisposedOfBySaleMember2025-03-14 00014461592025-03-142025-03-14 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembersrt:MaximumMember2026-09-112026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-01-012025-09-30 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-07-012025-09-30 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-01-012026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2026-07-012026-09-11 0001446159agpu:DataMedsAIIncFormerlyWellgisticsHealthIncMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2025-12-31 0001446159agpu:AssetsNotYetServiceMember2026-09-30 0001446159agpu:ConvertiblePromissoryNoteMember2026-09-112026-09-11 0001446159agpu:ConvertiblePromissoryNoteMember2026-09-30 0001446159srt:MaximumMemberagpu:ComputeAgreementsMember2026-01-012026-09-30 0001446159us-gaap:OfficeEquipmentMembersrt:MaximumMember2026-09-30 0001446159us-gaap:OfficeEquipmentMembersrt:MinimumMember2026-09-30 0001446159us-gaap:TechnologyEquipmentMembersrt:MaximumMember2026-09-30 0001446159us-gaap:TechnologyEquipmentMembersrt:MinimumMember2026-09-30 0001446159agpu:ReverseStockSplitMember2025-09-262025-09-29 0001446159agpu:ReverseStockSplitMember2025-09-292025-09-29 0001446159agpu:DuosEdgeAIGPUaaSLLCMember2026-09-30 0001446159agpu:DuosEdgeAIGPUaaSLLCMemberagpu:DeferredPurchasePricePayableMember2026-09-30 0001446159agpu:DuosEdgeAIGPUaaSLLCMemberagpu:DeferredPurchasePricePayableMember2026-09-302026-09-30 0001446159agpu:DuosEdgeAIGPUaaSLLCMember2026-09-302026-09-30 0001446159agpu:ConvertiblePromissoryNoteMember2025-01-012025-09-30 00014461592025-09-30 00014461592024-12-31 0001446159us-gaap:RetainedEarningsMember2025-09-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001446159us-gaap:CommonStockMember2025-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-09-30 0001446159us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001446159us-gaap:CommonStockMember2025-07-012025-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001446159us-gaap:PrivatePlacementMember2025-07-012025-09-30 0001446159us-gaap:RetainedEarningsMemberus-gaap:PrivatePlacementMember2025-07-012025-09-30 0001446159us-gaap:AdditionalPaidInCapitalMemberus-gaap:PrivatePlacementMember2025-07-012025-09-30 0001446159us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2025-07-012025-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberus-gaap:PrivatePlacementMember2025-07-012025-09-30 0001446159agpu:YorkvilleSEPAMember2025-07-012025-09-30 0001446159us-gaap:RetainedEarningsMemberagpu:YorkvilleSEPAMember2025-07-012025-09-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:YorkvilleSEPAMember2025-07-012025-09-30 0001446159us-gaap:CommonStockMemberagpu:YorkvilleSEPAMember2025-07-012025-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberagpu:YorkvilleSEPAMember2025-07-012025-09-30 0001446159agpu:AtTheMarketOfferingMember2025-07-012025-09-30 0001446159us-gaap:RetainedEarningsMemberagpu:AtTheMarketOfferingMember2025-07-012025-09-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:AtTheMarketOfferingMember2025-07-012025-09-30 0001446159us-gaap:CommonStockMemberagpu:AtTheMarketOfferingMember2025-07-012025-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberagpu:AtTheMarketOfferingMember2025-07-012025-09-30 00014461592025-06-30 0001446159us-gaap:RetainedEarningsMember2025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001446159us-gaap:CommonStockMember2025-06-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-06-30 00014461592025-04-012025-06-30 0001446159us-gaap:RetainedEarningsMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMember2025-04-012025-06-30 0001446159agpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:RetainedEarningsMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMemberagpu:AtTheMarketOfferingMember2025-04-012025-06-30 0001446159us-gaap:PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:RetainedEarningsMemberus-gaap:PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:AdditionalPaidInCapitalMemberus-gaap:PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:CommonStockMemberus-gaap:PrivatePlacementMember2025-04-012025-06-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMemberus-gaap:PrivatePlacementMember2025-04-012025-06-30 00014461592025-03-31 0001446159us-gaap:RetainedEarningsMember2025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-03-31 0001446159us-gaap:CommonStockMember2025-03-31 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-03-31 00014461592025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-31 0001446159agpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMemberagpu:RenovaroExtensionAgreementMember2025-01-012025-03-31 0001446159agpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:AdditionalPaidInCapitalMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMemberagpu:RegisteredDirectOfferingMember2025-01-012025-03-31 0001446159us-gaap:CommonStockMember2025-01-012025-03-31 0001446159us-gaap:RetainedEarningsMember2024-12-31 0001446159us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001446159us-gaap:CommonStockMember2024-12-31 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2024-12-31 0001446159us-gaap:RetainedEarningsMember2026-09-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001446159us-gaap:CommonStockMember2026-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-09-30 0001446159us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001446159us-gaap:CommonStockMember2026-07-012026-09-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-07-012026-09-30 0001446159us-gaap:RetainedEarningsMember2026-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001446159us-gaap:CommonStockMember2026-06-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-06-30 0001446159us-gaap:RetainedEarningsMember2026-04-012026-06-30 0001446159us-gaap:AdditionalPaidInCapitalMember2026-04-012026-06-30 0001446159us-gaap:CommonStockMember2026-04-012026-06-30 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-04-012026-06-30 0001446159us-gaap:RetainedEarningsMember2026-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2026-03-31 0001446159us-gaap:CommonStockMember2026-03-31 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2026-03-31 0001446159us-gaap:RetainedEarningsMember2026-01-012026-03-31 0001446159us-gaap:AdditionalPaidInCapitalMember2026-01-012026-03-31 0001446159us-gaap:CommonStockMember2026-01-012026-03-31 0001446159us-gaap:RetainedEarningsMember2025-12-31 0001446159us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001446159us-gaap:CommonStockMember2025-12-31 0001446159us-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember2025-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMember2025-12-31 0001446159agpu:SeriesBConvertiblePreferredStockMember2026-09-30 00014461592026-11-13
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________________________ to _________________________

 

Commission File Number: 001-36790

 

 

Axe Compute Inc.

 
 

(Exact name of registrant as specified in its charter)

 

 

Delaware

 

33-1007393

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

     

801 Brickell Avenue, Suite 510 Miami, Florida

 

33131

(Address of principal executive offices)

 

(Zip Code)

 

(305) 563-3850

(Registrant’s telephone number, including area code)

 

 

N/A

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: 

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, $0.01 par value

AGPU

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

☒ Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒ Yes   ☐ No

 

 

1

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer ☐

Non-accelerated filer ☒

Smaller reporting company ☒

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

☐ Yes   ☒ No

 

As of November 13, 2026, the registrant had 13,650,314 shares of common stock, par value $0.01 per share outstanding.

 

 

 

 

 

 

 

 

 

 

 

2

 

  

 

AXE COMPUTE INC.

 

TABLE OF CONTENTS

 

 

Page

PART I. FINANCIAL INFORMATION

4

   

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

5

   

CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2026 AND DECEMBER 31, 2025

5

   

CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (LOSS) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

6

   

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

7

   

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 AND 2025

9

   

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

10

   

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

32

   

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

40

   

ITEM 4. CONTROLS AND PROCEDURES

40

   

PART II. OTHER INFORMATION

40

   

ITEM 1. LEGAL PROCEEDINGS

40

   

ITEM 1A. RISK FACTORS

40

   

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

46

   

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

46

   

ITEM 4. MINE SAFETY DISCLOSURES

46

   

ITEM 5. OTHER INFORMATION

46

   

ITEM 6. EXHIBITS

46

   

SIGNATURES

47

 

 

3

 

  

 

PART I. FINANCIAL INFORMATION

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

In addition to historical information, certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, our results of operations, financial position and our business outlook, business trends and other information, may be forward-looking statements. You can identify these forward-looking statements by the words "believes," "intends," "expects," “might,” "may," "will," "should," "plans," "projects," "contemplates," "budgets," “potential,” "predicts," "estimates," "anticipates," “future,” “goal,” and variations of such words or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved, and actual future results may differ materially from what is expressed in or indicated by the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A, under the heading “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”) on March 31, 2026, and under “Part II, Item 1A., Risk Factors” in this Quarterly Report on Form 10-Q, if and as such risk factors may be updated from time to time in our periodic filings with the SEC. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and a reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

We caution you that the risks, uncertainties and other factors referenced above may not contain all of the risks, uncertainties and other factors that are important to you. In addition, we cannot assure you that we will realize the results, benefits or developments that we expect or anticipate or, even if substantially realized, that they will result in the consequences or affect us or our business in the way expected. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct, or (iv) our strategy, which is based in part on this analysis, will be successful. All forward-looking statements in this Quarterly Report on Form 10-Q apply only as of the date of this Quarterly Report on Form 10-Q or as of the date they were made or as otherwise specified herein. We assume no obligation to revise or update any forward-looking statements for any reason, except as required by law.

 

 

4

 
 

 

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

   

September 30,

2026

   

December 31,

2025

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 147,710,376     $ 10,756,507  

Accounts receivable

    1,033,953       -  

Compute prepayments

    28,629,743       -  

Other prepaid expense and current assets

    1,895,548       224,841  

Digital assets

    15,333,851       24,439,598  

Digital asset receivable

    13,369,361       7,226,475  

Current assets of discontinued operations

    -       122,526  

Total current assets

    207,972,832       42,769,947  
                 

Compute prepayments, net of current portion

    64,026,232       -  

Digital asset receivable, net of current portion

    2,920,242       8,258,681  

Property and equipment, net

    366,739,691       936  

Lease right-of-use assets

    38,053,385       -  

Investment in equity securities

    2,017,160       -  

Other long-term assets

    4,031       4,031  

Convertible note receivable

    4,322,840       -  

Non-current assets of discontinued operations

    -       1,854,751  
                 

Total assets

  $ 686,056,414     $ 52,888,346  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 627,528     $ 1,154,570  

Note payable

    291,722       107,951  

Accrued expenses and other liabilities

    3,024,722       1,393,203  

Deferred purchase price payable, net of discount

    36,597,577          

Contract liabilities

    100,881,687       -  

Lease liability

    15,470,820       -  

Current liabilities of discontinued operations

    -       1,611,172  

Total current liabilities

    156,894,056       4,266,896  
                 

Contract liabilities, net of current portion

    468,457,286       -  

Lease liability, net of current portion

    14,435,540       -  

Non-current liabilities of discontinued operations

    -       904,495  

Total liabilities

  $ 639,786,882     $ 5,171,391  
                 

Stockholders’ equity:

               
Preferred stock, 20,000,000 shares authorized inclusive of designated below                

Series B Convertible Preferred Stock, $.01 par value, 2,300,000 shares authorized, 79,246 shares outstanding as of September 30, 2026 and December 31, 2025

    792       792  

Common stock, $.01 par value, 200,000,000 shares authorized, 13,634,097 and 4,083,173 shares outstanding as of September 30, 2026, and December 31, 2025, respectively

    136,341       40,832  

Additional paid-in capital

    473,065,089       461,196,805  

Accumulated deficit

    (426,932,690 )     (413,521,474 )

Total stockholders’ equity

    46,269,532       47,716,955  
                 

Total liabilities and stockholders’ equity

  $ 686,056,414     $ 52,888,346  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

5

 
 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (LOSS)

(Unaudited)

 

    Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $ 7,243,043     $ -     $ 10,457,323     $ -  
                                 

Gains (losses) on digital assets

    10,477,971       -       (6,943,649 )     -  
                                 

Operating costs and expenses:

                               

Cost of revenues

  $ 6,911,526     $ -     $ 9,924,677     $ -  

General and administrative

    2,927,402       2,148,635       7,672,685       5,056,852  

Sales and marketing

    1,056,189       133,494       2,240,369       406,086  

Total operating costs and expenses

    10,895,117       2,282,129       19,837,731       5,462,938  
                                 

Total operating income (loss)

  $ 6,825,897     $ (2,282,129 )   $ (16,324,057 )   $ (5,462,938 )
                                 

Other income

    414,216       2,630       545,178       11,793  

Other expense

    (61,529

)

    (3,504 )     (64,511 )     (6,752 )

Unrealized gain

    4,557,443               4,557,443          

Gain (loss) on derivative instruments

    -       (74,366,000

)

    -       (74,366,000

)

                                 

Income (loss) from continuing operations

    11,736,027       (76,649,003 )     (11,285,947 )     (79,823,897 )

Loss from discontinued operations

    (591,266 )     (1,002,841 )     (2,484,118 )     (2,341,282 )

Gain on disposal of discontinued operations

    358,846       -       358,846       -  
                                 

Net income (loss)

  $ 11,503,607     $ (77,651,844 )   $ (13,411,219 )   $ (82,165,179 )
                                 

Income (loss) per common share, basic

                               

Income (loss) from continuing operations

  $ 0.55     $ (105.87 )   $ (0.54 )   $ (132.25 )

Loss from discontinued operations

    (0.01 )     (1.39 )     (0.10 )     (3.88 )

Net income (loss) per common share, basic

  $ 0.54     $ (107.26 )   $ (0.64 )   $ (136.13 )
                                 
Income (loss) per common share, diluted                                
Income (loss) from continuing operations   $ 0.53     $ (105.87 )   $ (0.54 )   $ (132.25 )
Loss from discontinued operations     (0.01 )     (1.39 )     (0.10 )     (3.88 )
Net income (loss) per common share, diluted   $ 0.52     $ (107.26 )   $ (0.64 )   $ (136.13 )
                                 

Weighted average shares used in computation – basic

    21,370,333       723,998       20,893,225       603,605  
Weighted average shares used in computation – diluted     21,956,645       723,998       20,893,225       603,605  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

6

 
 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE AND NINE MONTHS ENDED

SEPTEMBER 30, 2026 and 2025

(Unaudited)

 

   

Series B Preferred

   

Common Stock

   

Additional
Paid-In

   

Accumulated

         
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2025

    79,246     $ 792       4,083,173     $ 40,832     $ 461,196,805     $ (413,521,474 )   $ 47,716,955  

Share-based compensation related to instruments granted to employees

    -       -       -       -       111,358       -       111,358  

Issuance of common stock, net, in connection with restricted stock units vesting

    -       -       13,242       132       (17,576 )     -       (17,444 )

Issuance of shares to non-employees

    -       -       23,613       237       168,597       -       168,833  

Issuance of shares pursuant to pre-funded warrant exercises

    -       -       1,419,239       14,193       (14,192 )     -       1  

Net loss

    -       -       -       -       -       (7,708,943 )     (7,708,943 )

Balance at March 31, 2026

    79,246     $ 792       5,539,267     $ 55,394     $ 461,444,992     $ (421,230,417 )   $ 40,270,761  

Share-based compensation related to instruments granted to employees

    -       -       -       -       571,584       -       571,584  

Issuance of shares pursuant to At The Market Offering, net of issuance costs

    -       -       1,063,864       10,638       10,325,486       -       10,336,124  

Issuance of common stock, net, in connection with restricted stock units vesting

    -       -       26,393       264       (56,941 )     -       (56,677 )

Issuance of shares to non-employees

    -       -       27,984       279       129,006       -       129,285  

Issuance of shares pursuant to pre-funded warrant exercises

    -       -       4,727,432       47,274       (47,274 )     -       -  

Net loss

    -       -       -       -       -       (17,205,882 )     (17,205,882 )

Balance at June 30, 2026

    79,246     $ 792       11,384,940     $ 113,849     $ 472,366,853     $ (438,436,299 )   $ 34,045,195  

Share-based compensation related to instruments granted to employees

    -       -       -       -       621,339       -       621,339  

Issuance of shares to non-employees

    -       -       13,112       131       99,258       -       99,388  

Issuance of shares pursuant to pre-funded warrant exercises

    -       -       2,236,045       22,360       (22,360 )     -       -  

Net income

    -       -       -       -       -       11,503,607       11,503,607  

Balance at September 30, 2026

    79,246     $ 792       13,634,097     $ 136,341       473,065,089     $ (426,932,690 )     46,269,532  

 

 

 

 

7

 

   

Series B Preferred

   

Common Stock

   

Additional
Paid-In

   

Accumulated

         
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Total

 

Balance at December 31, 2024

    79,246     $ 792       444,475     $ 4,445     $ 180,218,424     $ (180,426,271 )   $ (202,610 )

Issuance of shares pursuant to warrant exercises

    -       -       95,601       956       1,533,426       -       1,534,382  

Issuance of shares pursuant to Registered Direct Offering, net of issuance costs

    -       -       24,223       242       465,063       -       465,305  

Issuance of shares pursuant to Renovaro Extension Agreement

    -       -       31,153       312       499,688       -       500,000  

Net loss

    -       -       -       -       -       (2,442,873 )     (2,442,873 )

Balance at March 31, 2025

    79,246     $ 792       595,452     $ 5,955     $ 182,716,601     $ (182,869,144 )   $ (145,796 )

Issuance of shares pursuant to May 2025 private placement

    -       -       18,692       187       299,813       -       300,000  

Issuance of shares pursuant to At The Market Offering, net of issuance costs

    -       -       18,987       190       162,668       -       162,858  

Issuance of shares to non-employees

    -       -       6,667       67       99,933       -       100,000  

Net loss

    -       -       -       -       -       (2,070,462 )     (2,070,462 )

Balance at June 30, 2025

    79,246     $ 792       639,798     $ 6,399     $ 183,279,017     $ (184,939,606 )   $ (1,653,400 )

Vesting expense

    -       -       -       -       371,335       -       371,335  

Issuance of shares pursuant to At The Market Offering, net of issuance costs

    -       -       78,356       784       920,564       -       921,348  

Issuance of commitment fee shares pursuant to Yorkville SEPA

    -       -       8,033       80       99,920       -       100,000  

Issuance of shares pursuant to August 2025 private placement

    -       -       36,237       362       412,731       -       413,093  

Round up of fractional shares pursuant to reverse stock split

    -       -       176       1       (1 )     -       -  

Issuance of shares pursuant to warrant exercises

    -       -       4,458       45       71,500       -       71,545  

Net loss

    -       -       -       -       -       (77,651,844 )     (77,651,844 )

Balance at September 30, 2025

    79,246     $ 792       767,058     $ 7,671       185,155,064     $ (262,591,449 )   $ (77,427,922 )

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

 

8

 
 

 

AXE COMPUTE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

    Nine Months Ended

September 30,

 
   

2026

   

2025

 

Cash flow from continuing operating activities:

               

Net loss

  $ (13,411,219

)

  $ (82,165,179

)

Add back: loss from discontinued operations

    2,484,118       2,341,282  

Less: (gain) on disposal of discontinued operations

    (358,846 )     -  

Net loss from continuing operations

    (11,285,947 )     (79,823,897 )

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    936       2,399  

Amortization of operating lease right-of-use assets

    4,662,505       -  

Share-based compensation

    1,304,281       259,355  

Issuance of shares to non-employees

    397,507       200,000  
Cost of booking compute     1,357,651       -  
Unrealized loss on digital assets     5,159,063       -  

Realized loss on digital assets

    1,784,586       -  

Loss on derivative instruments

    -       74,366,000  
                 

Changes in assets and liabilities:

               

Accounts receivable

    (1,033,952 )     6,742  

Other prepaid expense and other assets

    (1,670,707 )     (580,942 )

Compute prepayments

    (92,655,975 )     -  

Lease prepayments capitalized in right-of-use assets

    (9,279,153 )     -  

Accounts payable

    (527,042 )     1,761,220  

Accrued expenses and other liabilities

    1,355,795       394,085  

Contract liabilities

    569,194,897       -  

Operating lease liability

    (3,530,378 )     -  

Net cash provided by (used in) continuing operating activities:

    465,234,067       (3,415,038 )
                 

Cash flow from continuing investing activities:

               

Purchase of property and equipment

    (242,324,142 )     -  

Acquisition of Duos Cluster through purchase of SPV interests

    (87,817,973 )     -  
Unrealized (gain) on equity securities and convertible note receivable     (4,557,443 )     -  

Net cash (used in) continuing investing activities:

    (334,699,558 )     -  
                 

Cash flow from continuing financing activities:

               

Proceeds from issuance of common stock and warrants

    10,546,811       4,609,409  

Costs to issue common stock and warrants

    (210,687 )     (240,878 )

Payments for taxes related to net share settlement of restricted stock units

    (74,121 )     -  

Proceeds from issuance of financing note payable

    413,611       264,048  

Repayment of note payable

    (229,840 )     (76,674 )

Net cash provided by continuing financing activities:

    10,445,774       4,555,905  
                 

Discontinued operations:

               

Net cash (used in) operating activities

    (2,408,893 )     (2,318,873 )

Net cash provided by (used in) investing activities

    (1,620,366 )     625,000  

Net cash provided by (used in) financing activities

    -       -  

Net cash (used in) discontinued operations

    (4,029,259 )     (1,693,873 )
                 

Net increase (decrease) in cash

    136,951,024       (553,006 )

Cash and cash equivalents from continuing operations at beginning of period

    10,756,507       574,142  

Cash and cash equivalents from discontinued operations at beginning of period

    34,343       160,531  

Less: Cash from discontinued operations at end of period

    (31,498 )     (36,198 )

Cash and cash equivalents from continuing operations at end of period

  $ 147,710,376     $ 145,469  
                 

Supplemental disclosure for cash flow information:

               

Cash payments for interest

  $ 7,137     $ 4,956  
                 

Non-cash transactions:

               

Right-of-use assets obtained in exchange for operating lease liabilities

  $ 33,436,738     $ -  

Investment in equity securities received as consideration on sale

    572,695       -  

Convertible note receivable received as consideration on sale

    1,209,862       -  
Unrealized gain on equity securities     1,444,465          

Unrealized gain on convertible note receivable

    3,112,978       -  

Accrued severance, COBRA and malpractice tail related to disposal

    275,724       -  

Deferred purchase price issued for acquisition of Duos Cluster, net of discount

    36,597,577       -  

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

9

 

 

AXE COMPUTE INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

 

NOTE 1 – COMPANY INFORMATION

 

Nature of Operations

 

Axe Compute Inc. is a technology company focused on providing high-performance computing infrastructure for artificial intelligence (“AI”) workloads by sourcing large-scale graphics processing unit (“GPU”) capacity from hardware manufacturers and infrastructure suppliers and deploying that capacity for enterprise customers under long-term service agreements. The Company assists customers across the full GPU infrastructure stack, including hardware procurement, colocation, networking, storage, and financing, and can immediately access compute capacity through relationships with third party compute providers to provide customers compute capacity that is already online and available for rent.

 

The Company’s principal revenue-generating activity is the provision of GPU compute to customers. The Company primarily provides compute services under two customer models: (1) designing and deploying customized, large scale compute infrastructure solutions for enterprise clients; and (2) providing immediate access to GPU capacity (in as little as 24-48 hours) that is already online and available for rent from third parties.

 

For customers seeking large-scale, long-duration GPU compute capacity, the Company builds and deploys dedicated compute infrastructure solutions. Under this model, customers contract for dedicated AI infrastructure tailored to their compute, performance, geographic, security, and operational requirements. The Company coordinates with customers to architect deployments that may include GPU compute, high-speed storage, networking, power infrastructure, and related managed services. Deployments are typically hosted in enterprise-grade data center facilities and are operated by the Company pursuant to service level commitments. The Company intends to finance and then retain ownership of the deployed hardware and related infrastructure, while providing customers access to the infrastructure through multi-year service agreements. Customer contracts are typically structured with deposits, prepayments, and recurring monthly payments, including take-or-pay provisions intended to provide income visibility throughout the contract term.

 

For customers that need immediate access to GPU compute capacity, the Company provides access to high-performance GPU compute infrastructure. Our access to third-party networks encompasses global locations and GPUs capable of supporting a broad range of artificial intelligence, machine learning, and high-performance computing workloads. Compute capacity is delivered to customers through a managed infrastructure model, typically within 48 hours of customer engagement, without requiring customers to make capital investments in physical hardware or data center facilities.

 

For further discussion of the Company’s operating segments as of and for the three and nine months ended September 30, 2026, see Note 14 – Segment Information.

 

Disposal of Helomics Corporation

 

On September 11, 2026, the Company sold all of the issued and outstanding shares of its subsidiary, Helomics Corporation (“Helomics”), to DataMeds AI, Inc. (“DataMeds”) in exchange for DataMeds common stock and a convertible promissory note. The sale completed the Company’s strategic shift to focus on GPU compute infrastructure, and Helomics’ results are presented as discontinued operations for all periods presented. See Note 3 – Discontinued Operations for additional information. At September 30, 2026, the DataMeds common stock and convertible note receivable were carried at fair value (see Note 6 – Fair Value Measurements).

 

10

 

Acquisition of Axe Compute Acquisition Co. I, LLC

 

On September 30, 2026, the Company acquired 100% of the membership interests of Duos Edge AI – GPUaaS, LLC from Duos Technologies Group, Inc. (“Duos”) under a Membership Interest Purchase Agreement and subsequently renamed the acquired entity to Axe Compute Acquisition Co. I, LLC (the “SPV”). The SPV’s sole material assets are a cluster of 288 Supermicro NVIDIA B300 NVL8 servers containing 2,304 GPUs (the “Cluster”) and related contracts. The Company determined that substantially all of the fair value of the gross assets acquired is concentrated in a group of similar identifiable assets and, accordingly, accounted for the transaction as an asset acquisition under ASC 805-50, “Business Combinations – Related Issues.” No goodwill was recognized.

 

Consideration consisted of (i) cash of $87.8 million paid at closing to satisfy the SPV’s outstanding borrowings and related obligations under its loan and security agreement plus other closing fees, and (ii) a deferred purchase price of $42.9 million payable to Duos in monthly installments of $715,000 over an initial 60-month term. The Company is required to pay all remaining unpaid amounts of the deferred purchase price on the earlier of September 30, 2027 and the date on which the Company or an affiliate enters into a financing secured by the Cluster. Duos holds a security interest in the Cluster until the deferred purchase price is paid in full.

 

Because the deferred purchase price bears no stated interest, the Company recorded it at its present value of $36.6 million, using an imputed interest rate of 17.71% and an expected term of 12 months, which reflects the mandatory payment date. The resulting discount of $6.3 million is presented as a reduction of the liability and will be recognized as interest expense under the effective interest method. The liability is classified as current. The total cost of the assets acquired of $124.4 million, consisting of cash paid and the present value of the deferred purchase price plus capitalized transaction costs, was recorded within property and equipment, net.

 

Strategic Compute Reserve

 

On September 29, 2025, the Company adopted a treasury strategy centered on ATH, the native utility token of the Aethir network. Aethir is a decentralized physical infrastructure network developed by DCI Foundation, a Panama foundation company ("DCI"), that aggregates enterprise-grade GPU resources to support artificial intelligence, cloud gaming and other compute-intensive workloads. ATH functions as a proxy for a unit of GPU compute power and serves as the medium of exchange and incentive mechanism for participants in the Aethir network.

 

Under this strategy, the Company maintains a Strategic Compute Reserve comprised primarily of ATH, which provides the Company with immediate access to GPU compute capacity that can be deployed to customers. As a holder of ATH, the Company accrues unrealized gains or losses from any appreciation or depreciation, as applicable, in the value of ATH tokens, which trade on various cryptocurrency exchanges.

 

The Company seeks to generate value from its ATH holdings principally by utilizing ATH to procure GPU compute capacity on the Aethir network and reselling that capacity to enterprise, research and commercial customers. The Company has not engaged in ATH staking to date and does not currently intend to stake ATH, although it may elect to do so in the future.

 

11

 

The Company's Strategic Compute Reserve is intended to create value for stockholders through:

 

 

●

Maintaining access to GPU compute capacity through ownership of ATH;

 

 

●

Deploying ATH to acquire compute capacity and reselling that capacity to customers;

 

 

●

Opportunistically purchasing ATH in the open market, including receiving additional ATH incentives under the DCI agreement;

 

 

●

Earning yield through lending arrangements and other approved treasury activities;

 

 

●

Holding ATH as a strategic reserve to support future compute demand; and

 

 

●

Selling ATH from time to time to support working capital requirements, operational needs or other corporate purposes.

 

Refer to "Risks and Uncertainties" below for further discussion regarding risks related to the Company's Strategic Compute Reserve.

 

Liquidity

 

Since the adoption of the Company’s treasury strategy based on ATH, the Company has raised capital through private investment in public equity (“PIPE”) transactions and at-the-market (“ATM”) sales of shares of common stock. Additional details regarding these equity offerings are included in Note 11 – Stockholders’ Equity. These capital raises have strengthened the Company’s liquidity position, and the $147.7 million of cash and cash equivalents remaining as of September 30, 2026, together with $15.3 million of digital assets, represent readily accessible sources of liquidity. The Company believes its sources of liquidity will be sufficient to allow the Company to fund its planned operations for at least the next twelve months from the date of this Quarterly Report on Form 10-Q.

 

Reverse Stock Split

 

On September 19, 2025, the Company’s stockholders approved an amendment to the Company’s certificate of incorporation, as amended, to effect a one-for-fifteen reverse stock split of the Company’s common stock. On September 29, 2025, the Company completed a one-for-fifteen reverse stock split that was effective for trading purposes on September 30, 2025 (the “Reverse Stock Split”). All numbers of shares and per-share amounts in this report have been adjusted to reflect the Reverse Stock Split.

 

As a result of the Reverse Stock Split, every 15 shares of issued and outstanding common stock were combined into one issued and outstanding share of common stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split and any fractional shares that would otherwise have resulted from the Reverse Stock Split were rounded up to the nearest whole share. The Reverse Stock Split did not change the total number of authorized shares of common stock or preferred stock.

 

12

  

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Principles of Consolidation

 

The Company has prepared the condensed consolidated financial statements and related unaudited financial information in the notes in accordance with GAAP and the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim condensed consolidated financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. These interim condensed consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which in the opinion of management, are necessary to present fairly the Company’s position, the results of its operations, and its cash flows for the interim periods. These interim condensed consolidated financial statements reflect all intercompany eliminations. These interim condensed consolidated financial statements should be read in conjunction with the annual consolidated financial statements and the notes thereto contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026.

 

As of September 30, 2026, the Company had one operating subsidiary, the SPV mentioned above in Note 1. As of September 30, 2025, the Company had two wholly owned subsidiaries, Helomics Corporation and Skyline Medical Inc. (“Skyline Medical”). On September 11, 2026, the Company sold the Helomics Corporation subsidiary pursuant to a stock purchase agreement with DataMeds AI, Inc. On March 14, 2025, the Company sold the Skyline Medical business pursuant to an asset purchase agreement with DeRoyal Industries, Inc.; however, Skyline Medical remained a wholly owned subsidiary of Axe Compute following the transaction, with its activities limited to wind-down efforts that were substantially completed as of December 31, 2025. This subsidiary was dissolved as of September 30, 2026. The condensed consolidated financial statements include the accounts of the Company and these wholly owned subsidiaries, with all intercompany transactions and balances eliminated, as of and for the nine months ended September 30, 2026 and 2025.

 

Discontinued Operations

 

In September 2026, the Company disposed of the Helomics Corporation subsidiary. This disposal meets the criteria provided in ASC 205-20-45 and is classified as discontinued operations. In March 2025, the Company disposed of its former Eagan operating segment. Disposal groups that meet the discontinued operations criteria provided in ASC 205-20-45 are classified as discontinued operations.

 

Assets and liabilities of discontinued operations are presented separately in the Company’s condensed consolidated balance sheets and results of discontinued operations are reported as a separate component of net loss in the Company’s condensed consolidated statements of net income (loss) for all periods presented, resulting in changes to the presentation of certain prior period amounts. Cash flows from discontinued operations are also reported separately in the Company’s condensed consolidated statements of cash flows.

 

Refer to Note 3 – Discontinued Operations for additional discussion of discontinued operations. All other notes to these condensed consolidated financial statements present the results of continuing operations and exclude amounts related to discontinued operations for all periods presented.

 

Accounting Policies and Use of Estimates

 

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and during the reporting period. Actual results could materially differ from those estimates. Estimates are used in the following areas, among others: variable consideration associated with revenue recognition, stock-based compensation expense, fair value of derivatives including embedded derivatives, fair value of digital assets, fair value of long-lived assets for impairment analyses, the valuation allowance included in the deferred income tax calculation, accrued expenses, useful lives assigned to property and equipment, and determination of contract commencement dates. The Company bases its estimates on historical experience and assumptions that management considers reasonable. Assumptions are reviewed regularly to ensure they remain relevant and reasonable, particularly in areas of high subjectivity.

 

13

 

 

Note 2 to the annual consolidated financial statements contained in the Annual Report on Form 10-K filed with the SEC on March 31, 2026, describes the significant accounting policies and estimates used in preparation of the consolidated financial statements. There have been no material changes in the Company’s significant accounting policies during the nine months ended September 30, 2026, with the exception of the items noted below.

 

Revenues from GPU Compute Services

 

Revenue from the Company’s GPU compute services segment is generated from subscription-based arrangements with enterprise, research, and commercial customers under master services agreements and related order forms. These arrangements provide customers with continuous access to specified GPU compute resources (including GPU type, quantity, and configuration) at designated data center locations over defined service periods, which may range from month-to-month to multi-year terms. Certain contracts also include ancillary storage services, which are accounted for as separate performance obligations when distinct.

 

The Company procures GPU compute capacity from third-party node operators and decentralized cloud infrastructure platforms and resells that capacity to its customers. The Company has concluded that it acts as a principal in these arrangements, as it controls the GPU compute services prior to transferring to the customer, including directing the use of, and obtaining substantially all benefits from, the underlying capacity. Additionally, the Company bears inventory risk and has full discretion regarding the pricing of contracts with customers. Accordingly, revenue is recognized on a gross basis.

 

GPU compute and related storage services are each considered a series of distinct services that are substantially the same and are satisfied over time, as customers simultaneously receive and consume the benefits of these services as they are provided. Revenue is recognized over time using an output method that faithfully depicts the Company’s performance. For fixed-fee arrangements, revenue is recognized on a straight-line basis over the applicable service period, as the customer receives a consistent level of benefit throughout the term. Usage-based fees, including overage charges based on GPU-hours consumed in excess of contractual limits, are recognized as revenue in the period in which the usage occurs.

 

The transaction price primarily consists of fixed monthly subscription fees, which are generally non-cancellable and non-refundable during the contract term. Arrangements might include usage-based overages; however, for the period ended September 30, 2026, any variable consideration was immaterial. Variable consideration is included in revenue only to the extent it is probable that a significant reversal will not occur. For contracts with multiple performance obligations, such as combined GPU compute and storage services, the transaction price is allocated to performance obligations based on relative standalone selling prices. The Company has concluded that these arrangements do not contain significant financing components.

 

Property and equipment

 

Property and equipment are stated at cost less accumulated depreciation. Construction-in-progress is related to the construction or development of property and equipment that has not yet been placed into service for its intended use. Depreciation of property and equipment is computed using the straight-line method over the estimated useful lives of the respective assets.

 

The estimated useful lives of the Company’s property and equipment are as follows:

 

 

Years

Technology equipment

5

-

7

Computers, software, and office equipment

3

-

10

 

Upon retirement or sale of property and equipment, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is recorded in operations. Expenditures for maintenance and repairs that do not extend the lives of the respective assets are expensed as incurred.

 

14

 

Compute prepayments

 

The Company enters into agreements with third-party vendors to reserve and obtain GPU compute capacity, related storage, networking, and support services. Under these arrangements, the Company is generally required to make prepayments equal to either (1) a percentage of overall contract value or (2) a value equal to the monthly service payment for a number of months. In addition to these prepayments, the Company has monthly service payments over contract terms ranging from 12 to 36 months.

 

Upon transferring these prepayments, the Company records a compute prepayment as a prepaid asset. The prepaid balance is subsequently recognized as expense over the period in which the related services are received. For arrangements where the prepayment represents an advance payment for services evenly consumed over the contract term, the prepaid balance is amortized on a straight-line basis over the applicable service period. For arrangements where the prepayment relates to specific months of service, the prepaid balance is relieved and recognized as expense in the months to which the prepayment applies, consistent with the pattern of benefit received. Monthly service payments are recognized as expense as incurred in accordance with the underlying contractual terms. The Company evaluates compute prepayments each reporting period to determine whether the recorded balance remains recoverable and appropriately reflects expected future service consumption.

 

The timing of service deployment and commencement under certain compute capacity arrangements is dependent on a variety of third-party factors, including original equipment manufacturer (“OEM”) schedules, GPU allocation timing, logistics, and other operational dependencies. As a result, at the time a compute prepayment is made, the exact period over which the prepaid balance will be utilized may not be known with certainty. Management is therefore required to estimate the expected service commencement date and the period over which the related services will be received in order to determine the appropriate classification of compute prepayments between current and non-current assets and to establish the amortization period. These estimates are based on the facts and circumstances known at the reporting date and are reassessed each reporting period. Changes in actual deployment timing or service consumption patterns may result in adjustments to the classification and timing of expense recognition in future periods.

 

Leases

 

The Company has lease agreements for GPU equipment. The Company accounts for leases in accordance with ASC 842, Leases (“ASC 842”). The Company determines if an arrangement meets the definition of a lease at inception and leases are classified at commencement.

 

Right-of-use (“ROU”) assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation associated with the lease agreement. Lease liabilities are measured at the commencement date based on the present value of the remaining lease payments over the lease term. ROU assets are measured at commencement at an amount equal to the lease liability, adjusted for prepaid lease payments. The Company’s leases do not provide an implicit interest rate; therefore, the Company uses the incremental borrowing rate determined at lease commencement, based on the estimated interest rate for collateralized borrowings with similar terms, payments, and economic environments.

 

The lease term includes the non-cancelable period of the lease and periods covered by renewal options that the Company is reasonably certain to exercise. When assessing the reasonableness of exercising lease renewal options, the Company takes into account all relevant facts and circumstances that contribute to the economic benefits associated with exercising the lease renewal options, which includes the expected changes in facts and circumstances between the commencement of the lease term and the exercise date of the options. Payments under the Company's lease agreements are fixed.

 

The Company made an accounting policy election for lease agreements with a term of 12 months or less and does not recognize ROU assets and lease liabilities in respect of those agreements. Any payments related to short-term leases are expensed as incurred. The Company has elected the practical expedient to not separate lease and non-lease components across all asset classes. Operating lease expense is recognized on a straight-line basis within cost of revenues in the consolidated statements of net income (loss). The Company currently does not have any lease arrangements with residual value guarantees.

 

15

 

Fair Value Option

 

The Company may elect to measure certain eligible financial instruments at fair value at initial recognition under ASC 825-10, Financial Instruments – Overall (the “fair value option”). The election is made on an instrument-by-instrument basis, applies only to the instrument for which it is made, and is irrevocable once made. For instruments measured under the fair value option, subsequent changes in fair value are recognized in net income (loss) each period, and transaction costs are expensed as incurred.

 

On September 11, 2026, in connection with the sale of Helomics (see Note 3), the Company received a convertible promissory note from DataMeds and elected the fair value option for the note. The Company elected the fair value option because measuring the entire instrument at fair value more faithfully reflects its economics. The note was initially recorded at its fair value of $1.2 million and is carried at $4.3 million as of September 30, 2026. The change in fair value, is presented in “Unrealized gain (loss)” in the condensed consolidated statements of net income (loss) and totaled $3.1 million for the three and nine months ended September 30, 2026. Interest accrued at the stated 7% rate is presented separately as interest income and the fair value of the note is a Level 3 measurement, see Note 6.

 

Risks and Uncertainties

 

Note 2 to the annual consolidated financial statements in the Annual Report on Form 10-K filed March 31, 2026 describes certain risks and uncertainties relevant to the Company’s financial statements. Since that report, the Company has expanded its business to purchase, own and operate GPU computing infrastructure and entered into large multi-year customer contracts. The following risks and uncertainties relate to that expansion and should be read together with the information in the 10-K. Additional risk factors are in Part II, Item 1A of this Quarterly Report.

 

Use of estimates. Certain estimates are subject to change in the near term (ASC 275-10-50-8) and could be materially different in future periods. These include the estimated useful lives and recoverability of the Company’s property and equipment ($366.7 million, none yet placed in service), the incremental borrowing rate and imputed interest rate used to measure lease liabilities and the deferred purchase price, the fair value of Level 3 financial instruments (the embedded derivative and the DataMeds convertible note), the timing of contract commencement, and the classification of compute prepayments between current and non-current. Actual results could differ from these estimates. 

 

Recently Issued Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”). Recently issued ASUs not listed below either were assessed and determined to be not applicable or are currently expected to have no impact on the consolidated financial statements of the Company.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires more detailed disclosures related to certain costs and expenses. The guidance requires entities to disclose amounts of certain expense categories included in expense captions presented on the face of the income statement, including purchases of inventory, employee compensation, depreciation, and intangible asset amortization. This ASU is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The disclosure requirements may be applied either prospectively or retrospectively. Management is currently evaluating this ASU to determine its impact on the Company’s disclosures.

 

16

  

 

NOTE 3 – DISCONTINUED OPERATIONS

 

Helomics Corporation

 

On September 11, 2026, the Company sold all of the issued and outstanding shares of Helomics Corporation ("Helomics") to DataMeds AI, Inc. (formerly Wellgistics Health, Inc.; Nasdaq: MEDS) ("DataMeds") under a Stock Purchase Agreement (the "DataMeds SPA"). The SPA was signed and the sale closed on the same day.

 

In exchange for the Helomics shares, the Company received, 636,328 shares of DataMeds common stock, equal to 19.99% of DataMeds's shares outstanding immediately before closing; and a convertible promissory note with a principal amount of $1,363,672. The note bears simple interest at 7% per year, matures on September 11, 2029, and is unsecured and subordinated to DataMeds's bank and institutional debt. Interest is not payable until maturity or conversion. The note converts into DataMeds common stock at a fixed price of $1.00 per share automatically when DataMeds's stockholders approve the issuance under Nasdaq rules. DataMeds must hold the stockholder meeting within 75 days of closing.

 

At closing, the Company also paid DataMeds $1,500,000 in cash, representative of the remaining base rent obligations under the Helomics leases assigned as part of the transaction. The DataMeds shares, the note and the shares issuable on conversion are restricted securities and cannot be transferred for 12 months after closing, with limited exceptions.

 

Below details the calculation of the gain on disposal of discontinued operations associated with the disposal of the Helomics business on September 11, 2026:

 

Cash paid to DataMeds

  $ (1,500,000 )

Fair value of the convertible note

    1,209,862  

Fair value of the equity securities received

    572,695  

Net assets and liabilities of discontinued operations

    450,249  

Costs of disposal (1)

    (373,960 )

Gain on disposal of discontinued operations

  $ 358,846  

 

 

(1)

Costs of disposal were legal fees and severance payments associated with the sale.

 

The sale represents the finalization of a strategic shift taken by the Company to focus on GPU compute infrastructure. Accordingly, Helomics's results are presented as discontinued operations in the condensed consolidated statements of operations for all periods presented, and its assets and liabilities are presented as assets and liabilities of discontinued operations in the prior-period balance sheet.

 

The balance sheet as of September 30, 2026, does not include any assets and liabilities of discontinued operations related to Helomics Corporation. The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities as of the September 11, 2026, closing date to the gain on sale recorded in the statement of net income (loss) for the three and nine months ended September 30, 2026, and the carrying amounts of the major classes of assets and liabilities as of December 31, 2025:

 

   

At disposal on September 11, 2026

   

December 31, 2025

 

Cash and cash equivalents

  $ 31,498     $ 34,343  

Accounts Receivable, net

    61,011       32,120  

Prepaid Expense and Other Current Assets

    42,814       56,063  

Total current assets of discontinued operations

    135,322       122,526  
                 

Property and Equipment, net

    173,948       222,192  

Lease Right of Use Assets

    1,073,709       1,487,703  

Prepaid Expense and Other Long-Term Assets

    98,478       98,478  

Intangibles, net

    43,326       46,378  

Total assets of discontinued operations

  $ 1,524,784     $ 1,977,277  
                 

Accounts Payable

  $ 597,148     $ 686,038  

Accrued Expenses and Other Liabilities

    245,170       271,391  

Lease Liability

    727,103       653,743  

Total current liabilities of discontinued operations

    1,569,421       1,611,172  
                 

Lease Liability, net of current portion

    405,612       904,495  

Total liabilities of discontinued operations

  $ 1,975,033     $ 2,515,667  

 

17

 

The following table provides details about the major classes of line items constituting the loss from discontinued operations presented in the Company’s condensed consolidated statement of net income (loss) for the three and nine months ended September 30, 2026:

 

    Three Months Ended

September 30, 2026

   

Nine Months Ended
September 30, 2026

 

Revenue

 

$

1,823     $ 37,846  
                 

Costs and operating expenses

               

Cost of revenues

  $ 1,970     $ 5,015  

General and administrative

    353,138       1,257,408  

Research and development

    338,954       1,374,031  

Sales and marketing

    -       369  

Total operating costs and expenses

    694,062       2,636,823  
                 

Total operating (loss)

  $ (692,239 )   $ (2,598,977 )
                 

Other income

    100,973       114,859  
                 

Loss from discontinued operations

  $ (591,266 )   $ (2,484,118 )

 

    Three Months Ended

September 30, 2025

   

Nine Months Ended
September 30, 2025

 

Revenue

 

$

3,618     $ 116,610  
                 

Costs and operating expenses

               

Cost of revenues

  $ 8,356     $ 71,695  

General and administrative

    551,160       1,431,120  

Research and development

    441,837       1,377,637  

Total operating costs and expenses

    1,001,353       2,880,452  
                 

Total operating (loss)

  $ (997,735 )   $ (2,763,842 )
                 

Other income (expense)

    -       676,690  
                 

Net (loss) from discontinued operations

  $ (997,735 )   $ (2,087,152 )

 

For the nine months ended September 30, 2026, discontinued operations used $2.4 million of cash in operating activities and $1.6 million in investing activities. Depreciation and amortization included in discontinued operations was $0.1 million. The disposal used $1.63 million of cash: the $1.5 million paid to DataMeds, $31,498 of cash held by Helomics at closing, and $0.1 million of costs paid to sell.

 

Skyline Medical

 

On March 14, 2025, the Company entered into an asset purchase agreement (the “APA”) and closed the transactions contemplated therein with DeRoyal Industries, Inc., a Tennessee corporation (“DeRoyal”), to sell and assign to DeRoyal assets and liabilities exclusively related to the business of providing products for automated, direct-to-drain medical fluid disposal, including the Company’s STREAMWAY® product line (the “Eagan Business”). These assets were operated by the Company’s wholly owned subsidiary, Skyline Medical, and were previously reported in the Company’s Eagan operating segment. The purchased assets exclusively related to the Eagan Business included but were not limited to cash, certain accounts receivable, inventories, patents, fixed assets, and real property leased by the Company and exclusively used in connection with the Eagan Business. The total purchase price for the assets was $625,000, plus the assumption of certain liabilities related to the Eagan Business including the lease for the office and warehouse space located at 2915 Commers Drive Suite 900 Eagan, MN 55121, certain accounts payable, and contract liabilities associated with the Eagan Business. The ongoing activities of the former Eagan operating segment are limited to wind down activities. As a result of these developments, the former Eagan operating segments have been reclassified to discontinued operations in these condensed consolidated financial statements for all periods presented.

 

18

 

The balance sheet as of September 30, 2026, does not include any assets and liabilities of discontinued operations related to Skyline Medical. The following table presents a reconciliation of the carrying amounts of the major classes of assets and liabilities to the current assets and liabilities of discontinued operations as presented in the Company’s condensed consolidated balance sheet as of September 30, 2025:

 

   

September 30, 2025

 

Assets:

       

Prepaid expense and other assets

  $ 14,348  

Total current assets of discontinued operations

    14,348  
         

Total assets of discontinued operations

  $ 14,348  
         

Liabilities:

       

Accounts payable

  $ 6,183  

Accrued expenses and other liabilities

    303,863  

Total current liabilities of discontinued operations

    310,046  
         
         

Total liabilities of discontinued operations

  $ 310,046  

 

The statement of net income (loss) as of September 30, 2026, does not include any discontinued operation activity related to the Skyline Medical business. The following table provides details about the major classes of line items constituting the loss from discontinued operations presented in the Company’s condensed consolidated statement of net income (loss) for the three and nine months ended September 30, 2025:

 

    For the three months ended

September 30, 2025

   

For the nine months ended

September 30, 2025

 

Revenue

 

$

-     $ 157,179  

Cost of sales

    -       122,800  

Gross profit from discontinued operations

    -       34,379  
                 

Operating expenses:

               

General and administrative

    5,106       209,447  

Research and development

    -       125,495  

Sales and marketing

    -       130,318  

Total operating expenses

    5,106       465,260  

Total operating (loss) from discontinued operations

    (5,106 )     (430,881 )

Gain on disposal of discontinued operations

    -       172,451  

Other income

    -       4,300  

Net (loss) from discontinued operations

 

$

(5,106 )   $ (254,130 )

 

The gain on disposal of discontinued operations represents the gain on assets sold and liabilities assumed by DeRoyal.

 

 

NOTE 4 – REVENUE RECOGNITION AND CONTRACTS WITH CUSTOMERS

 

Disaggregation of Revenue

 

The Company primarily generates its revenue through providing GPU compute services for fixed term contracts. Revenue recognized related to fixed term contracts represented all of the revenue for the three and nine months ended September 30, 2026.

 

Contracts with Customers

 

The following customers accounted for 10% or more of the Company’s revenue for the periods presented:

 

   

Three Months Ended September 30,

   

Nine months Ended September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Customer A

    22 %     *       30 %     *  

Customer B

    58 %     *       48 %     *  

 

* Customer did not represent 10% or more of revenue.

 

19

 

Customer A and B accounted for 51% and 3% of accounts receivable, net, respectively, as of September 30, 2026. Two customers not noted above accounted for 15% and 14% of accounts receivable, net, respectively, as of September 30, 2026. All other single customers represent less than 10% of revenue and accounts receivable, net, for the three- and nine-month periods ended and as of September 30, 2026.

 

The Company monitors the creditworthiness of its customers on an ongoing basis and believes that its credit risk is limited due to the financial strength and payment history of these customers. Management does not expect any material losses from these receivable concentrations and has not recorded an allowance for doubtful accounts, as all receivables are considered highly collectible.

 

Contract Balances

 

Contract assets represent the Company’s rights to consideration in exchange for compute services. The Company had no contract assets as of the periods presented, as the Company’s right to consideration becomes unconditional upon invoicing (which occurs at or before the service period commences) and does not depend on any factor other than passage of time.

 

The Company’s contract liabilities are comprised of prepayments received from compute services customers, i.e. deferred revenue. The Company invoices for services and once the Company receives consideration (or has an unconditional right to consideration) before services are fulfilled, the Company recognizes a contract liability for the unfulfilled performance obligation. These prepayments are classified as contract liabilities, current or non-current, until the appropriate revenue recognition criteria have been met. As of September 30, 2026, the Company had contract liabilities of $569.3 million. As of December 31, 2025, the Company had no contract liabilities.

 

The following table represents a reconciliation of the changes in the Company’s contract liabilities:

 

   

September 30, 2026

 

Balance, beginning of period – December 31, 2025

  $ -  

Advance billings

    579,796,296  

Revenue recognized

    (10,457,323 )

Balance, end of period

  $ 569,338,973  

 

As of September 30, 2026, the Company had $569.3 million of remaining performance obligations. The Company expects to recognize revenue associated with these performance obligations as follows:

 

2026 (remaining 3 months)

  $ 8,104,000  

2027

    129,093,077  

2028

    127,220,420  

2029

    304,921,476  
    $ 569,338,973  

 

Compute Prepayments

 

In connection with the Company’s compute services business, as the Company receives prepayments from Customers, the Company also makes prepayments to vendors for access to Compute capacity. As of September 30, 2026, the Company has recorded $92.7 million in prepayments. $85.6 million of those prepayments relate to leases for compute capacity that have not commenced as of September 30, 2026, and $7.1 million relates to prepayments for compute capacity and expenses.

  

 

NOTE 5 – DIGITAL ASSETS

 

The Company’s digital assets, as presented on the condensed consolidated balance sheets for the periods indicated, consist primarily of ATH. ATH qualifies for recurring fair-value measurement under ASC 350-60, Intangibles — Goodwill and Other — Accounting for and Disclosure of Crypto Assets, with changes in fair value recognized in earnings in accordance with ASC 820, Fair Value Measurement, based on quoted (unadjusted) prices on the principal market of the Company for ATH (Level 1 inputs). The following table summarizes the number of units held, cost basis, and fair value of ATH as of September 30, 2026 and December 31, 2025:

 

   

Units Held

   

Cost Basis

   

Fair Value

 

September 30, 2026

    2,555,010,735     $ 93,830,989     $ 15,171,654  

December 31, 2025

    2,837,163,868     $ 101,258,178     $ 24,439,334  

 

Cost basis represents the purchase price of digital assets, including transaction fees, if any, at the time of acquisition or upon receipt. Fair value represents quoted prices for the digital assets in the Company’s principal market at 11:59 p.m. Eastern Time on each reporting date in accordance with the Company’s crypto-asset valuation policy.

 

20

 

The following table represents a reconciliation of digital assets held, for ATH specific activity:

 

   

For the nine months ended
September 30, 2026

 

Fair Value, December 31, 2025

  $ 24,439,334  
         

Purchases of ATH

    -  

ATH used in operations

    (1,480,709 )

Interest income from ATH loaned

    76,896  
Realized (loss)     (1,784,586 )
Unrealized (loss)     (6,079,281 )

Fair Value, September 30, 2026

  $ 15,171,654  

 

   

For the three months ended
September 30, 2026

 

Fair Value, June 30, 2026

  $ 11,144,775  
         

Purchases of ATH

    -  

ATH used in operations

    (337,487 )
Realized (loss)     (454,732 )

Unrealized gain

    4,819,098  
Fair Value, September 30, 2026   $ 15,171,654  

 

As of September 30, 2026, the Company held $0.1 million of non-ATH digital assets.

 

ATH tokens were utilized primarily for the rental of GPU compute capacity on the Aethir decentralized infrastructure network, supporting the Company's compute-related operations.

 

During the nine months ended September 30, 2026, the Company generated ATH-denominated digital asset lending income through a digital asset lending arrangement. The Company transferred 2.4 billion ATH tokens via the Aethir portal for a defined period of time of 31 calendar days. The lending arrangement accrued interest at a fixed annual rate of 6%, calculated on a simple interest basis. Upon expiration of the term of the digital asset lending arrangement, the principal amount and accrued interest were repaid in full. For the nine months ended September 30, 2026, the Company recognized digital asset lending income of $0.1 million. As of September 30, 2026, no digital assets held by the Company were subject to the lending arrangement.

 

Side Letter

 

In connection with private placement transactions completed in October 2025 to support the Company’s treasury strategy, the Company entered into a side letter agreement (the “Side Letter”) with DCI, effective October 7, 2025. Pursuant to the Side Letter, for each ATH token purchased by the Company in the open market, whether through centralized or decentralized exchanges operating on the Ethereum Network, DCI will grant the Company additional ATH tokens equal to 20% of the number of tokens purchased (the “Bonus ATH”), to be delivered within 30 days of the related purchase. The Bonus ATH is not subject to restrictions upon receipt.

 

The Company accounts for the Side Letter as a derivative instrument. As of September 30, 2026 and December 31, 2025, respectively, no derivative asset was recognized, as all Bonus ATH associated with open market purchases made during the period had been received from DCI.

 

For the nine months ended September 30, 2026, the Company did not receive any Bonus ATH as there were no open market purchases of ATH made during the period. The cost basis of the ATH received in prior periods pursuant to the Side Letter and subsequent fair value adjustments thereto are recorded within “Gains (losses) on digital assets” on the condensed consolidated statements of net income (loss).

 

Digital asset receivable

 

A portion of the Company’s ATH holdings consists of contractual rights to receive ATH tokens that are subject to time-based vesting and transfer restrictions (“Locked ATH”). Locked ATH was obtained pursuant to Simple Agreements for Future Tokens (“SAFTs”) and is administered through an on-chain smart contract deployed on the Ethereum mainnet. Prior to vesting and claim, the Company does not have control of the underlying ATH tokens and is not able to transfer, sell, stake, pledge, or otherwise deploy such tokens.

 

The smart contract enforces the applicable vesting schedules and restricts access to the ATH tokens until the vesting conditions are satisfied. Upon satisfaction of the vesting conditions, the Company must affirmatively claim the unlocked ATH tokens through the smart contract interface, at which point the tokens are released from restriction and transferred to a Company-controlled wallet. Until such claim occurs, the Locked ATH represents a contractual right to receive ATH in the future rather than a digital asset held by the Company.

 

21

 

As of September 30, 2026, the Company held rights to receive ATH tokens that remain subject to vesting and claim requirements. The vesting period for these ATH tokens ranges from less than one month to approximately 2 years. These restrictions are specific to the underlying ATH tokens. Upon vesting and claim, the restrictions lapse and the Company obtains control of the ATH tokens, which may then be held, transferred to custodial accounts, staked, or otherwise deployed in accordance with the Company’s treasury strategy.

 

As of September 30, 2026, the Company recorded a digital asset receivable of $16.3 million related to the Locked ATH, consisting of a host receivable of $93.4 million, net of an embedded derivative liability measured at fair value of $77.1 million. The change in fair value of the embedded derivative of $6.0 million and $0.8 million for the three and nine months ended September 30, 2026, was recognized within “Gains (losses) on digital assets” in the condensed consolidated statements of net income (loss).

 

As of December 31, 2025, the Company recorded a digital asset receivable of $15.5 million related to the Locked ATH, consisting of a host receivable of $93.4 million, net of an embedded derivative liability measured at fair value of $77.9 million. The change in fair value of the embedded derivative of $77.9 million for the year ended December 31, 2025, was recognized within “Gains (losses) on digital assets” in the condensed consolidated statements of net income (loss).

 

 

NOTE 6 – FAIR VALUE MEASUREMENTS

 

The following tables present information about the Company’s financial assets and liabilities measured at fair value on a recurring basis and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value as of September 30, 2026 and December 31, 2025, respectively. Financial assets and liabilities measured at fair value on a recurring basis include cash equivalents, digital assets, the embedded derivative related to the digital asset receivable, and the investment in DataMeds common stock and the DataMeds convertible note receivable received in connection with the sale of Helomics (see Note 3). Fair value estimates do not necessarily represent the amounts that may be ultimately realized.

 

September 30, 2026

 

Fair Value

   

Level 1

   

Level 2

   

Level 3

 

Assets:

                               

Cash equivalents

  $ 138,000,000     $ 138,000,000     $ -     $ -  

Digital assets

    15,333,851       15,333,851       -       -  

Investment in DataMeds common stock

    2,017,160       2,017,160       -       -  

DataMeds convertible note receivable

    4,322,840       -       -       4,322,840  

Liabilities:

                               

Embedded derivative related to digital asset receivable

  $ (77,089,490 )   $ -     $ -     $ (77,089,490 )

 

December 31, 2025

 

Fair Value

   

Level 1

   

Level 2

   

Level 3

 

Assets:

                               

Digital assets

  $ 24,439,598     $ 24,439,598     $ -     $ -  

Liabilities:

                               

Embedded derivative related to digital asset receivable

  $ (77,893,482 )   $ -     $ -     $ (77,893,482 )

 

Cash equivalents represent the Company’s money market investments. The fair value of these investments is based on the daily market price for identical assets in active markets.

 

The Company received 636,328 shares of DataMeds common stock on September 11, 2026, with an initial fair value of $0.6 million ($0.90 per share). The shares are measured at fair value under ASC 321, with changes recognized in “Unrealized gain (loss)”. Fair value is based on the quoted closing price of $3.17 per share. The Company considered the effect of the 12-month transfer restriction and concluded that no adjustment was required as there is no indication of lack of marketability. The Company recognized an unrealized gain of $1,444,465 for the three and nine months ended September 30, 2026.

 

The convertible note, which has a principal $1.4 million subject to the following terms, 7% simple interest, maturity at September 11, 2029, convertible at $1.00 per share upon DataMeds stockholder approval under Nasdaq rules was initially recorded at fair value of $1,209,862 and is measured at fair value under the fair value option (see Note 2). Because the note is not traded, its fair value is a Level 3 measurement. The Company estimated fair value using an as-converted valuation based on the DataMeds share price, adjusted for the probability of stockholder approval, and credit risk. In accordance with ASC 820, no discount or fair value adjustment has been applied for the 12-month contractual lock-up restriction as it is holder-specific. The contractual lock-up restricts the transfer or sale of the converted shares by the holder for 12 months following issuance but does not alter the underlying economic rights of the instrument. Key unobservable inputs as of September 30, 2026 were certainty of stockholder approval, a 4.06% risk free rate, a 15.7% credit yield and expected volatility of 138.4%. The Company recognized an unrealized gain of $3.1 million for the three and nine months ended September 30, 2026.

 

22

 

The embedded derivative related to the digital asset receivable must be remeasured at fair value each reporting period in accordance with ASC 815, Derivatives and Hedging. Because there is no directly observable market for illiquid, contractually restricted ATH tokens subject to a time-based vesting schedule, the embedded derivative related to digital asset receivable is classified as Level 3. The key unobservable input is the discount applied to reflect the lack of transferability and control during the restriction period. The discount is determined based on the remaining vesting period from each reporting period to the date on which the tokens become fully vested and available to claim, and is reduced ratably at each subsequent measurement date until it reaches zero at full vesting. As of the nine months ended September 30, 2026, applied discounts ranged from approximately 15% to 41%. As of December 31, 2025, applied discounts ranged from approximately 30% to 55%. Changes in fair value of the embedded derivative are recognized in the consolidated statements of net income (loss) within "Gains (losses) on digital assets." There were no transfers into or out of Level 3 of the fair value hierarchy during the nine months ended September 30, 2026, or the year ended December 31, 2025.

 

The following tables present summaries of the changes in the fair value on a recurring basis of the Company’s Level 3 financial instruments for the periods presented:

 

   

Embedded derivative
related to digital asset
receivable

   

DataMeds
convertible note

   

Total

 

Balance at December 31, 2025

  $ (77,893,482 )   $ -     $ (77,893,482 )

Adjustment to fair value

    (119,544 )     -       (119,544 )

Balance at March 31, 2026

    (78,013,025 )     -       (78,013,025 )

Adjustment to fair value

    (5,073,843 )     -       (5,073,843 )

Balance at June 30, 2026

    (83,086,868 )     -       (83,086,868 )

Initial Recognition (September 11, 2026)

    -       1,209,862       1,209,862  

Adjustment to fair value

    5,997,378       3,112,978       9,110,356  

Balance at September 30, 2026

  $ (77,089,490 )   $ 4,322,840       (72,766,650 )

 

Nonrecurring Fair Value Measurement

 

The Company measured the liability for the Guarantee Side Letter (see Note 8) at fair value on a nonrecurring basis at inception on September 30, 2026. The measurement is classified as Level 3 because it relies on significant unobservable inputs. The fair value of approximately $1.2 million was estimated as the probability-weighted expected payment on two months of guaranteed fees of $6.9 million per month, assuming a 100% loss and using an 8.6% probability of default. The effect of discounting was immaterial. The liability is not remeasured at fair value after initial recognition.

 

23

 

  

 

NOTE 7 – PROPERTY AND EQUIPMENT, NET

 

The Company’s property and equipment, net consisted of the following:

 

   

As of

September 30,

2026

   

As of

December 31,

2025

 

Computers, software, and office equipment

 

$

42,964    

$

42,964  

Construction in progress - Technology equipment

    366,739,691       -  

Total

    366,782,655       42,964  

Less: Accumulated depreciation

    (42,964 )     (42,029 )

Total Property and equipment, net

  $ 366,739,691     $ 936  

 

Depreciation expense, recorded within general and administrative expenses of continuing operations, was $0 and $800 for the three months ended September 30, 2026 and 2025, respectively, and $936 and $2,400 for the nine months ended September 30, 2026 and 2025, respectively.

 

During the three months ended September 30, 2026, the Company purchased $225.2 million of infrastructure equipment related to ongoing Build model contracts. As of September 30, 2026, the entirety of the technology equipment balance represents construction in progress.

 

On September 30, 2026, the Company acquired the Cluster through the acquisition of the SPV, as described in Note 1, at a total cost of $124.4 million. The Cluster was acquired on the last day of the period and was not yet placed in service; therefore, no depreciation was recorded on it for the three and nine months ended September 30, 2026. As of September 30, 2026, the Cluster was included in construction in progress.

 

No impairment charges related to property and equipment held and used in continuing operations were incurred during the three and nine months ended September 30, 2026 and 2025.

 

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Commitments

 

During the three and nine months ended September 30, 2026, the Company entered into several agreements with third-party vendors to reserve and obtain access to GPU compute capacity, related storage, networking, and support services. Management has evaluated these arrangements and concluded that they are service commitments and not leases. Under these arrangements, the Company is generally required to make upfront payments and, following service commencement or operational activation, monthly service payments over contract terms of approximately 12 months. These arrangements represent total contractual commitments to be paid according to the following schedule:

 

2026 (remaining 3 months)

  $ 66,024  

2027

    123,651  

Total

  $ 189,675  

 

Deferred Purchase Price and Side Letter

 

The Company is obligated to pay Duos the remaining deferred purchase price described in Note 1. Assuming payment in full on the September 30, 2027, outside date, contractual payments are $2.1 million in the remaining three months of 2026 and $40.8 million in 2027, for a total of $42.9 million before the $6.3 million unamortized discount. The obligation is secured by Duos’ security interest in the Cluster.

 

The Company also entered a side letter (the “Guarantee Side Letter”) with Duos Edge AI, Inc. (“Duos Edge”), an affiliate of Duos, pursuant to which the Company unconditionally guarantees payment of unpaid amounts owed by certain customers of Duos Edge under agreements which the Company approves in writing. The Company accounts for the guarantee under ASC 460, Guarantees, and recognized a liability of approximately $1.2 million at its inception-date fair value. No allowance for expected credit losses was recorded because the expected loss was immaterial.

 

Litigation

 

In the ordinary course of business, the Company may be subject from time to time to various proceedings, lawsuits, disputes, or claims. In accordance with ASC 450, Contingencies (“ASC 450”), the Company accrues a liability for legal contingencies when it is probable that a liability has been incurred, and the amount of the loss can be reasonably estimated. If there is at least a reasonable possibility that a loss may be incurred, ASC 450 requires disclosure of a loss contingency.

 

There have been no material changes to the Company’s contingencies as disclosed in the Form 10-K for the year ended December 31, 2025.

 

24

  

 

NOTE 9 – LEASES

 

The Company has entered into several lease agreements with third-party vendors to reserve and obtain access to GPU compute capacity, related storage, networking, and support services. These lease agreements have terms of 2-3 years extending through July 30, 2029, no purchase or renewal options that the Company is reasonably certain to exercise.

 

Lease expense under operating lease arrangements, recorded within costs of revenue of continuing operations, was $5.0 million for the three and nine months ended September 30, 2026. There was no lease expense for the three and nine months ended September 30, 2025.

 

The following table summarizes the operating lease asset and liabilities recorded as of September 30, 2026 and December 31, 2025:

 

    September 30,

2026

   

December 31,

2025

 

Operating lease right-of-use asset, gross

  $ 42,715,891     $ -  

Accumulated amortization

    (4,662,505 )     -  

Operating lease right-of-use asset, net

  $ 38,053,385     $ -  
                 

Short-term operating lease liabilities

    15,470,820       -  

Long-term operating lease liabilities

    14,435,540       -  

Total operating lease liabilities

  $ 29,906,360     $ -  
                 

Weighted average remaining lease term – operating leases in years

    1.96       -  

Weighted average discount rate – operating leases

    12.3 %     -  

 

Cash paid for operating cash flows used in operating activities included in the measurement of lease liabilities was $4.0 million and $4.6 million for the three and nine months ended September 30, 2026.

 

The Company’s operating lease obligations as of September 30, 2026, were as follows:

 

2026 (remaining 3 months)

  $ 4,499,210  

2027

    17,996,840  

2028

    9,658,584  

2029

    1,068,968  

Thereafter

    -  

Total lease payments

    33,223,602  

Less: interest

    (3,317,242 )

Present value of lease liabilities

  $ 29,906,360  

 

As of September 30, 2026, the Company had signed several lease agreements with Compute vendors that have not yet commenced. These leases are for access to compute capacity. The Company made prepayments related to these agreements totaling $85.6 million, which are recorded in Compute prepayments as of September 30, 2026. These leases are expected to commence in 2026 and 2027 with estimated lease terms of two to four years. Total future lease payments for leases committed to but not yet commenced was $407.4 million as of September 30, 2026.

 

 

NOTE 10 – NOTE PAYABLE

 

In June 2026, the Company purchased director and officer insurance policies with a policy period ending June 2027 and financed $0.4 million of its total premium by entering into a note payable with a finance provider that requires ten monthly installment payments through April 2027. The note is secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.1% over the life of the note. As of September 30, 2026, the outstanding balance of the note was $0.3 million including interest.

 

In June 2025, the Company purchased director and officer insurance policies with a policy period ending June 2026 and financed $0.3 million of its total premium by entering into a note payable with a finance provider that required ten monthly installment payments through April 2026. The note was secured by a first priority lien on the financed policies. The short-term note bears interest at an annual percentage rate of 6.6% over the life of the note. As of December 31, 2025, the outstanding balance of the note was $0.1 million including interest.

 

25

  

 

NOTE 11 – STOCKHOLDERS’ EQUITY

 

At The Market Offering

 

On May 3, 2024, the Company entered into an at-the-market (“ATM”) sales agreement (the “Sales Agreement”) with Wainwright & Co., LLC (“Wainwright”), under which it may issue and sell shares of its common stock, with Wainwright acting as sales agent and receiving a 3.0% commission on gross proceeds. The Company subsequently filed a shelf registration statement on Form S-3 (the “May 2024 Shelf Registration Statement”) and prospectus supplement.

 

On April 18, 2025, in accordance with the terms of the Sales Agreement, the Company filed a prospectus supplement to the May 2024 Shelf Registration Statement relating to the offer and sale of up to an additional $1.5 million of shares of the Company’s common stock.

 

On September 2, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $1.4 million remaining as of May 31, 2025, up to an aggregate of $3.4 million, and the Company filed an additional prospectus supplement with the SEC on September 2, 2025.

 

On October 29, 2025, in accordance with the terms of the Sales Agreement, the Company determined to further increase the number of shares it may sell under the Sales Agreement, from the approximately $2.3 million remaining as of September 30, 2025, up to an aggregate of $18.3 million, and the Company filed an additional prospectus supplement with the SEC on October 29, 2025.

 

During April 2026, the Company sold 1,063,864 shares of common stock pursuant to the Sales Agreement at an average price of approximately $10.22 per share, resulting in approximately $10.3 million in aggregate net proceeds, after deducting commissions and offering costs.

 

On May 15, 2026, in accordance with the terms of the Sales Agreement, the Company filed an additional prospectus supplement with the SEC increasing the aggregate amount of common stock that may be offered and sold under the Sales Agreement to up to $100 million, inclusive of approximately $17.0 million of shares previously sold under the Sales Agreement, resulting in approximately $83.0 million remaining available to the Company for future sales thereunder. Since the Company's public float exceeded $75.0 million as of May 15, 2026, the Company is no longer subject to the baby shelf limitations of General Instruction I.B.6 of Form S-3.

 

As of September 30, 2026, approximately $83.0 million remained available to the Company for sales under the Sales Agreement.

 

September 2025 Private Placements and Related Agreements

 

On September 29, 2025, the Company entered into a securities purchase agreement (the “Crypto SPA”) with certain accredited investors pursuant to which the Company agreed to sell and issue to such investors in a private placement (the “Crypto PIPE Offering”) pre-funded warrants (the “Crypto PIPE Warrants”). Also on September 29, 2025, the Company entered into a securities purchase agreement (the “Cash SPA,” and together with the Crypto SPA, the “September SPAs”), pursuant to which it agreed to sell and issue to certain accredited investors, in exchange for cash (the “Cash PIPE Offering,” and together with the Crypto PIPE Offering, the “PIPE Offerings”), the Company’s common stock and warrants (the “Cash PIPE Warrants”). The PIPE Offerings closed October 7, 2025 (the “Closing Date”).

 

Cash PIPE and Crypto PIPE

 

In the Cash PIPE Offering, the Company sold an aggregate of 4,366,703 shares of common stock (or pre-funded warrants at a nominal $0.01 exercise price per share to purchase shares of common stock, in lieu thereof) to certain accredited investors for $11.6265 per share. In the Crypto PIPE, the Company issued, to certain accredited investors, Crypto PIPE Warrants to purchase up to 14,903,393 shares of its common stock at a nominal $0.01 exercise price per share.

 

There were 8,382,716 pre-funded warrants exercised for the nine months ended September 30, 2026, and the total number of pre-funded warrants outstanding was 7,736,379 as of September 30, 2026, all of which were vested and exercisable and have no expiration date.

 

Stock Warrants

 

The following summarizes transactions for warrants for the period indicated: 

 

   

Number of
Shares

   

Weighted-
Average
Exercise
Price

 

Outstanding as of December 31, 2025

    1,623,179     $ 17.39  

Issued

    -       -  

Expired

    -       -  

Exercised

    (30,430 )     271.35  

Outstanding as of September 30, 2026

    1,592,749     $ 12.53  

 

There were no warrants granted for the nine months ended September 30, 2026 and 2025, respectively.

 

26

  

 

NOTE 12 – STOCK-BASED COMPENSATION

 

Equity Incentive Plan

 

On December 30, 2024, the Company’s stockholders approved the 2024 Equity Incentive Plan (the “2024 Plan”). The 2024 Plan allows for the issuance of non-statutory stock options and incentive stock options, stock appreciation rights, stock awards, restricted stock, restricted stock units, and performance awards to employees, directors, and consultants of the Company, where permitted under the plan. Due to the approval of the 2024 Plan, no new awards will be granted under the Company’s Amended and Restated 2012 Stock Incentive Plan. The exercise price for each stock option is determined by the market price on the date of issuance. Vesting requirements are determined by the Board of Directors when granted and currently range from immediate to three years. Options outstanding under this plan have a contractual life of ten years.

 

ASC 718, Compensation – Stock Compensation (“ASC 718”), requires that a company that issues equity as compensation record compensation expense that corresponds to the estimated cost of those equity grants. ASC 718 requires companies to estimate the fair value of stock-based payment awards on the date of grant using an option-pricing model or other acceptable means.

 

Restricted Stock Units

 

On September 9, 2025, the Board of Directors, upon the recommendation of the Compensation Committee of the Board of Directors (the “Compensation Committee”), determined that it was appropriate to award restricted stock units (“RSUs”) as a form of compensation for employees, consultants and directors and approved a form of Restricted Stock Unit Award Agreement, with such awards to be granted under the Company’s 2024 Plan. Consistent with that determination, the Board of Directors approved the grant of 60,101 RSUs on September 9, 2025. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs contained a service-based vesting condition requiring continued service through October 31, 2025, at which point the RSUs vested in full. The RSUs were settled on November 28, 2025.

 

On December 10, 2025, the Company entered into an amendment to the employment agreement with Raymond F. Vennare dated as of November 1, 2022. Pursuant to the amendment and following approval by the Compensation Committee, Mr. Vennare was awarded 20,000 RSUs. The RSUs contained a service-based vesting condition requiring continued service through January 1, 2026, at which point the RSUs vested in full. The RSUs were settled on February 5, 2026.

 

During the nine months ended September 30, 2026, 33,330 additional RSUs were granted to employees and consultants under the Company’s 2024 Plan. Each RSU represented the right to receive one share of the Company’s common stock upon vesting. The RSUs vested in full upon the RSU grant date.

 

The following table summarizes the Company’s RSU activity for the period indicated: 

 

   

Number of
Shares

   

Weighted-
Average Grant
Date Fair Value
per RSU

 

Non-vested RSUs as of December 31, 2025

    20,000     $ 5.92  

Granted

    33,330     $ 5.84  

Vested

    (53,330 )   $ 5.86  

Non-vested RSUs as of September 30, 2026

    -          

 

The Company has no unrecognized stock-based compensation expense related to RSUs that is expected to be recognized in a future period.

 

Stock Options

 

The Company determines the grant date fair value of options and warrants using a Black-Scholes option valuation model based upon assumptions regarding risk-free interest rate, expected dividend rate, volatility, and estimated term. There were 1,320,000 stock options granted for the nine months ended September 30, 2026. There were no stock options granted for the nine months ended September 30, 2025.

 

27

 

The following table summarizes the Company’s stock option activity for the period indicated:

 

    Number of
Shares
   

Weighted-
Average
Exercise
Price

    Weighted-
Average
Remaining
Contractual
Term
(Years)
   

Aggregate
Intrinsic
value

 

Outstanding as of December 31, 2025

    2,925     $ 1,334.98       2.99       -  

Issued

    1,320,000     $ 3.65       9.50     $ 10,524,004  

Expired

    (42 )   $ 3,055.79       -       -  

Exercised

    -       -       -       -  

Outstanding as of September 30, 2026

    1,322,883     $ 6.50       9.49     $ 10,524,004  

 

The fair value of each option grant for the nine months ended September 30, 2026 and 2025, was estimated on the grant date using the Black-Scholes option valuation model with the following assumptions:

 

    Nine months Ended September 30,  
   

2026

   

2025

 

Expected dividend yield

    0.0 %     0.0 %

Expected stock price volatility

    104.1 - 112.2 %     99.4 %

Risk-free interest rate

    4.22% - 4.8 %     4.37 %

Expected life (in years)

    10       5  

 

The Company has $3.4 million of unrecognized stock-based compensation expense related to stock options that is expected to be recognized over the next approximately three years.

 

Stock-Based Compensation Expense, Net

 

Stock-based compensation expense, net of forfeitures, recognized for the three and nine months ended September 30, 2026, was $0.6 million and $1.3 million, respectively. There was $0.3 million of compensation expense recognized for the three and nine months ended September 30, 2025. Such expense is included within general and administrative expenses in the condensed consolidated statements of net income (loss).

 

28

 

  

 

NOTE 13 – NET LOSS PER SHARE

 

Earnings per share accounting requires the presentation of both basic and diluted earnings per share on the face of the statements of net income (loss). Basic net income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Weighted-average common shares include 7,736,379 pre-funded warrants, because their exercise price is nominal ($0.01 per share) and there are no conditions that must be satisfied before they can be exercised.

 

Diluted net income (loss) per share adjusts the weighted-average shares for the dilutive effect of potential common shares. Dilutive effects of stock options and warrants are determined using the treasury stock method. Assumed proceeds include the exercise price and the average unrecognized stock-based compensation cost. Options granted during the period are weighted for the portion of the period outstanding. Potential common shares are excluded from diluted net loss per share when their effect would be anti-dilutive, which includes all potential common shares in periods when the Company reports a loss from continuing operations.

 

The following table presents the shares used in the basic and diluted loss per common share computations:

 

    Three months Ended

September 30,

   

Nine months Ended

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Numerator:

                               

Net income (loss) from continuing operations

  $ 11,736,027     $ (76,649,003 )   $ (11,285,947 )   $ (79,823,897 )

Net (loss) from discontinued operations

    (232,420 )     (1,002,841 )     (2,125,272 )     (2,341,282 )

Net income (loss) attributable to common stockholders

    11,503,607       (77,651,844 )     (13,411,219 )     (82,165,179 )
                                 

Denominator:

                               

Weighted average common shares outstanding - basic

    21,370,333       723,998       20,893,225       603,605  

Dilutive effect of stock options, warrants and preferred stock (1)(2)

    586,312       -       -       -  

Weighted average common shares outstanding - diluted

    21,956,645       723,998       20,893,225       603,605  

 

 

(1)

Dilutive effect for the three months ended September 30, 2026, by instrument is as follows:

 

Options

    586,310  

Series B Convertible Stock

    2  

Total dilutive shares

    586,312  

 

  (2) The following is a summary of the number of underlying shares outstanding at the end of the respective periods that have been excluded from the diluted calculations because the effect on loss per common share would have been anti-dilutive:

 

    Three Months Ended

September 30,

   

Nine months Ended

September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Options

    297,883       42,113       1,322,883       42,113  

Warrants

    1,592,749       940,412       1,592,749       940,412  

Restricted stock units

    -       -       -       -  

Preferred stock: Series B

    -       -       -       -  

  

 

NOTE 14 – SEGMENT INFORMATION

 

The Company’s operations are organized and managed as a single operating segment, which is also its sole reportable segment, the Compute Services and Treasury Management segment. The segment provides access to GPU compute capacity, including dedicated infrastructure deployed under the Company’s Build model, and manages the Company’s ATH treasury strategy. The Company determined its segment in accordance with ASC 280, Segment Reporting (“ASC 280”), based on how its Chief Operating Decision Maker (“CODM”) manages the business, which is on a consolidated basis. Following the September 2026 disposal of Helomics, which is presented as discontinued operations (Note 3), the Company has no other operating segments.

 

The CODM is the Company’s Chief Executive Officer. The CODM assesses segment performance and decides how to allocate resources, including capital deployed to compute infrastructure, operating expenses and the treasury strategy, using net income (loss) as reported on the condensed consolidated statements of net income (loss). The measure of segment profit or loss is consolidated net income (loss), and the accounting policies of the segment are those described in Note 2. The measure of segment assets is total consolidated assets, which were $686.1 million as of September 30, 2026 and $52.9 million as of December 31, 2025.

 

29

 

The following table presents segment revenue, significant segment expenses regularly provided to the CODM, and segment net income (loss) for the periods presented:

 

   

Three Months Ended September 30,

   

Nine months Ended September 30,

 
   

2026

   

2025

   

2026

   

2025

 

Revenue

  $ 7,243,043     $ -     $ 10,457,323     $ -  

Less significant segment expenses:

                               

Cost of revenues

    6,911,526       -       9,924,677       -  

General and administrative

    2,927,402       2,148,635       7,672,685       5,056,852  

Sales and marketing

    1,056,189       133,494       2,240,369       406,086  

Total significant segment expenses

    10,895,117       2,282,129       19,837,731       5,462,938  

Other segment items, net income (expense)¹

    15,155,681       (75,369,715 )     (4,030,811 )     (76,702,241 )

Segment and consolidated net income (loss)

  $ 11,503,607     $ (77,651,844 )   $ (13,411,219 )   $ (82,165,179 )

 

¹ Other segment items consist of gains and losses on digital assets, other income and expense, unrealized gains and losses on equity securities and the convertible note receivable, gains and losses on derivative instruments, and the results of discontinued operations.

 

Depreciation and amortization and interest expense are not significant to the segment’s results for the periods presented. All revenue for the three and nine months ended September 30, 2026 was generated from GPU compute services under fixed term contracts. Customers that accounted for 10% or more of revenue are presented in Note 4.

 

30

 

  

 

NOTE 15 – SUBSEQUENT EVENTS

 

Contracts with Penguin Solutions

 

In October 2026, the Company entered into a multi-year strategic partnership with Penguin Solutions (“Penguin”), pursuant to which Penguin will provide deployment and operational services at specified GPU cluster sites that the Company designs, owns and operates in connection with Axe Compute Build, its build-to-order program. The services include Penguin’s cluster management software and 24x7 network operations center coverage. The arrangement consists of a five-year term with the total fees over the initial term of $20.8 million. Installments are invoiced on completion of build and deployment services for the respective cluster and on each of the first four anniversaries of that completion.

 

Appointment of Director

 

Effective November 9, 2026, the Company’s Board of Directors appointed Guang Yang as an independent director and as Chair of the Audit Committee. The Board has determined that Mr. Yang qualifies as an audit committee financial expert under SEC rules. Following his appointment, the Board consists of five directors, a majority of whom are independent. Additional information regarding the appointment is included in the Company’s Current Report on Form 8-K filed with the SEC on November 13, 2026.

 

31

  

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes thereto included elsewhere in this Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2026, and our Form 10-K for the year ended December 31, 2025.

 

Certain information in this Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"). All statements, other than statements of historical facts, including statements concerning our plans, objectives, goals, beliefs, business strategies, future events, business conditions, our results of operations, financial position and our business outlook, business trends and other information, may be forward-looking statements. You can identify these forward-looking statements by the words "believes," "intends," "expects," “might,” "may," "will," "should," "plans," "projects," "contemplates," "budgets," “potential,” "predicts," "estimates," "anticipates," “future,” “goal,” and variations of such words or similar expressions. These statements are based on our beliefs, as well as assumptions we have used based upon information currently available to us. Because these statements reflect our current views concerning future events, these statements involve risks, uncertainties, and assumptions, many of which, by their nature, are inherently uncertain and beyond our control. Our expectations, beliefs, estimates and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved, and actual future results may differ materially from what is expressed in or indicated by the forward-looking statements. Factors that might cause such differences include, but are not limited to, those discussed in Part I, Item 1A, under the heading “Risk Factors,” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on March 31, 2026, and under “Part II, Item 1A., Risk Factors” in this Quarterly Report on Form 10-Q, if and as such risk factors may be updated from time to time in our periodic filings with the SEC. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and a reader, whether investing in our common stock or not, should not place undue reliance on these forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments.

 

Overview

 

Axe Compute Inc. is a technology company focused on providing high-performance computing infrastructure for artificial intelligence (“AI”) workloads by sourcing large-scale graphics processing unit (“GPU”) capacity from hardware manufacturers and infrastructure suppliers and deploying that capacity for enterprise customers under long-term service agreements. We assist customers across the full GPU infrastructure stack, including hardware procurement, colocation, networking, storage, and financing. We can also immediately access compute capacity through relationships with third party compute providers to provide customers compute capacity that is already online and available for rent.

 

Compute Services

 

Our principal revenue-generating activity is the provision of GPU compute to customers. We primarily provide compute services under two customer models: (1) designing and deploying customized, large scale compute infrastructure solutions for enterprise clients; and (2) providing immediate access to GPU capacity (in as little as 24-48 hours) that is already online and available for rent from third parties.

 

For customers seeking large-scale, long-duration GPU compute capacity, we build and deploy dedicated compute infrastructure solutions. Under this model, customers contract for dedicated AI infrastructure tailored to their compute, performance, geographic, security, and operational requirements. We coordinate with customers to architect deployments that may include GPU compute, high-speed storage, networking, power infrastructure, and related managed services. Deployments are typically hosted in enterprise-grade data center facilities and are operated by us pursuant to service level commitments. We intend to finance and then retain ownership of the deployed hardware and related infrastructure, while providing customers access to the infrastructure through multi-year service agreements. Customer contracts are typically structured with deposits, prepayments, and recurring monthly payments, including take-or-pay provisions intended to provide income visibility throughout the contract term.

 

32

 

 

For customers that need immediate access to GPU compute capacity, we provide access to high-performance GPU compute infrastructure. Our access to third-party networks encompasses global locations and GPUs capable of supporting a broad range of artificial intelligence, machine learning, and high-performance computing workloads. Compute capacity is delivered to customers through a managed infrastructure model, typically within 48 hours of customer engagement, without requiring customers to make capital investments in physical hardware or data center facilities.

 

Legacy Business

 

The provision of compute services is our priority and remains our focus. In September 2026, we sold Helomics Corporation (“Helomics”), the subsidiary through which we conducted our legacy oncology drug discovery business, to DataMeds AI, Inc. (“DataMeds”). The sale represents the finalization of our strategic shift to focus on GPU compute infrastructure. Helomics’ results are presented as discontinued operations for all periods presented, and we no longer conduct drug discovery operations. See Note 3 – Discontinued Operations to the unaudited condensed consolidated financial statements.

 

Strategic Compute Reserve

 

On September 29, 2025, we adopted a treasury strategy centered on ATH, the native utility token of the Aethir network. Aethir is a decentralized physical infrastructure network developed by DCI Foundation, a Panama foundation company ("DCI"), that aggregates enterprise-grade GPU resources to support artificial intelligence, cloud gaming and other compute-intensive workloads. ATH functions as a proxy for a unit of GPU compute power and serves as the medium of exchange and incentive mechanism for participants in the Aethir network.

 

Under this strategy, we maintain a Strategic Compute Reserve comprised primarily of ATH, which provides us with immediate access to GPU compute capacity that can be deployed to customers. As a holder of ATH, we accrue unrealized gains or losses from any appreciation or depreciation, as applicable, in the value of ATH tokens, which trade on various cryptocurrency exchanges.

 

We seek to generate value from our ATH holdings principally by utilizing ATH to procure GPU compute capacity on the Aethir network and reselling that capacity to enterprise, research, and commercial customers. We have not engaged in ATH staking to date and do not currently intend to stake ATH, although we may elect to do so in the future.

 

Our Strategic Compute Reserve is intended to create value for stockholders through:

 

 

●

Maintaining access to GPU compute capacity through ownership of ATH;

 

 

●

Deploying ATH to acquire compute capacity and reselling that capacity to customers;

 

 

●

Opportunistically purchasing ATH in the open market, including receiving additional ATH incentives under the DCI agreement;

 

 

●

Earning yield through lending arrangements and other approved treasury activities;

 

 

●

Holding ATH as a strategic reserve to support future compute demand; and

 

 

●

Selling ATH from time to time to support working capital requirements, operational needs or other corporate purposes.

 

There can be no assurance that the value of ATH will increase, and investors should carefully consider the risks associated with digital assets.

 

33

 

 

Recent Developments

 

During the nine months ended September 30, 2026, we appointed Kyle Okamoto as President effective April 1, 2026, and appointed Jeremy Yaukey-Witter as Chief Financial Officer effective May 18, 2026.

 

On May 15, 2026, in accordance with the terms of the ATM Sales Agreement with Wainwright, we determined to further increase the number of shares we may sell under the Sales Agreement up to an aggregate of $100.0 million, inclusive of approximately $17.0 million of shares previously sold under the Sales Agreement, and we filed an additional prospectus supplement with the SEC on May 15, 2026. The net proceeds from the shares offered and sold pursuant to the ATM Sales Agreement during the nine months ended September 30, 2026, after deduction of commissions and offering expenses, were approximately $10.3 million. As of September 30, 2026, approximately $83.0 million remained available for sales under the Sales Agreement.

 

In July 2026, we secured three new customer contracts with a total contract value of more than $2.8 billion across the United States and Europe. The agreements, secured through the Axe Compute Build program, expand our design-deploy-own-operate model into additional geographies and add significant dedicated, large-scale AI infrastructure capacity to our global footprint.

 

On September 11, 2026, we sold all of the issued and outstanding shares of Helomics to DataMeds in exchange for 636,328 shares of DataMeds common stock, representing 19.99% of DataMeds’ shares outstanding immediately before closing, and a convertible promissory note with a principal amount of $1.4 million. We also paid DataMeds $1.5 million in cash at closing, representing the remaining base rent obligations under the Helomics leases assigned in the transaction. We recognized a gain on disposal of $0.4 million, and Helomics’ results are presented as discontinued operations. See Note 3 – Discontinued Operations.

 

On September 30, 2026, we acquired 100% of the membership interests of Duos Edge AI – GPUaaS, LLC from Duos Technologies Group, Inc. (“Duos”) under an Equity Purchase Agreement and subsequently renamed the acquired entity to Axe Compute Acquisition Co. I, LLC (the “SPV”). The SPV’s sole material assets are a cluster of 288 Supermicro NVIDIA B300 NVL8 servers containing 2,304 GPUs (the “Cluster”) and related contracts. We paid $87.8 million in cash at closing to satisfy the SPV’s outstanding borrowings and related obligations and issued a deferred purchase price of $42.9 million, with all remaining unpaid amounts due on the earlier of September 30, 2027 and the date we or an affiliate enter into a financing secured by the Cluster. We accounted for the transaction as an asset acquisition and recorded the Cluster at a total cost of $124.4 million within property and equipment, net. See Note 1 and “Liquidity and Capital Resources—Financing Transactions” below. In connection with our acquisition of the SPV, the Company’s three-year customer contract for the dedicated cluster, previously announced in April 2026, was replaced with a five-year customer contract with similar commercial terms. The cluster is intended to support large-scale AI model training, fine-tuning, and high-throughput inference workloads. The infrastructure will maintain NVIDIA reference architecture throughout the contract period.

 

In connection with our ongoing Build model contracts, we purchased technology equipment of $225.2 million in the quarter ended September 30, 2026, excluding the Cluster acquired on September 30, 2026 via our acquisition of the SPV. This technology equipment consists of GPU cluster infrastructure and is considered construction in progress as of September 30, 2026 and will begin depreciating when placed in service.

 

Capital Requirements

 

Since inception, we have incurred recurring losses and have not generated sufficient revenues to fund our operations. Historically, we have financed our activities through a combination of debt and equity financings. Since 2023, we have monetized certain assets and reduced operating expenses. In September 2025, we adopted the aforementioned treasury strategy, which introduced both new sources of capital and additional capital requirements. See “Liquidity and Capital Resources—Liquidity and Plan of Financing” and “Liquidity and Capital Resources—Financing Transactions” below.

 

As of September 30, 2026, we had approximately $147.7 million in cash and cash equivalents. Additionally, we also hold significant ATH digital assets, which may serve as an additional source of liquidity. However, the market price of ATH has exhibited significant volatility over recent periods and remains subject to rapid fluctuations driven by factors such as market sentiment, regulatory developments, network adoption, governance decisions of the Aethir Foundation, and broader crypto-asset market conditions.

 

Additional sources of liquidity include our at-the-market (“ATM”) facility, under which approximately $83.0 million remains available as of the prospectus supplement filed with the SEC on May 15, 2026, as well as a standby equity purchase agreement (“SEPA”) that allows us to sell up to $10.0 million of our common stock, in each case subject to the terms, conditions, and limitations of the respective arrangements.

 

34

 

Our future cash requirements and the adequacy of our available resources will depend on our ability to generate revenue from our compute services and treasury strategy, as well as our ability to access additional financing. We expect operating losses to continue in the near term as we scale these initiatives. Given our recent strategic shift, our future operating results are inherently uncertain, and period-to-period comparisons may not be indicative of future performance.

 

Results of Operations

 

Comparison of the three months ended September 30, 2026 and 2025:

 

 

   

2026

   

2025

   

Difference

 

Revenue

  $ 7,243,043     $ -     $ 7,243,043  

Gains (losses) on digital assets

    10,477,971       -       10,477,971  

Cost of revenues

    6,911,526       -       6,911,526  

General and administrative expenses

    2,927,402       2,148,635       778,767  
                         

Sales and marketing expenses

    1,056,189       133,494       922,695  

Total operating gain (loss)

    6,825,897       (2,282,129 )     9,108,026  

Other income (expense)

    4,910,130       (74,366,874 )     79,277,004  

Income (loss) from continuing operations

    11,736,027       (76,649,003 )     88,385,030  

Income (loss) from discontinued operations

    (232,420 )     (1,002,841 )     770,421  

Net income (loss)

  $ 11,503,607     $ (77,651,844 )   $ 89,155,451  

 

Comparison of the nine months ended September 30, 2026 and 2025

 

   

2026

   

2025

   

Difference

 

Revenue

  $ 10,457,323     $ -     $ 10,457,323  

Gains (losses) on digital assets

    (6,943,649 )     -       (6,943,649 )

Cost of revenues

    9,924,677       -       9,924,677  

General and administrative expenses

    7,672,685       5,056,852       2,615,833  
                         

Sales and marketing expenses

    2,240,369       406,086       1,834,283  

Total operating gain (loss)

    (16,324,057 )     (5,462,938 )     (10,861,119 )

Other income (expense)

    5,038,110       (74,360,959 )     79,399,069  

Income (loss) from continuing operations

    (11,285,947 )     (79,823,897 )     68,537,950  

Income (loss) from discontinued operations

    (2,125,272 )     (2,341,282 )     216,010  

Net income (loss)

  $ (13,411,219 )   $ (82,165,179 )   $ 68,753,960  

 

Revenue. We recognized revenue of $10.5 million for the nine months ended September 30, 2026, compared to no revenue for the nine months ended September 30, 2025. Revenue was $7.2 million for the three months ended September 30, 2026. The increase was driven by the commencement of our compute services business: revenue in the current period was generated from GPU compute services provided under fixed term contracts, while there was no revenue in the prior-year period.

 

Gains (losses) on digital assets. We recorded a net loss on digital assets of $6.9 million in the nine months ended September 30, 2026, consisting of $5.2 million of unrealized losses and $1.8 million of realized losses, with no such losses recorded in the comparative period. For the three months ended September 30, 2026, we recorded a gain on digital assets of $10.5 million, reflecting increases in the fair value of our ATH holdings and of the embedded derivative related to our Locked ATH. The amounts in the 2026 period primarily represent the change in fair value of our ATH holdings, which were not present in the comparative period.

 

Cost of revenues. Cost of revenues was $9.9 million in the nine months ended September 30, 2026, including $6.9 million in the three months ended September 30, 2026, with no cost of revenues in the comparative period. Similar to revenue, the increase was due to the commencement of our compute services business and includes $5.0 million of operating lease expense for third-party compute capacity.

 

General and administrative expenses. General and administrative (“G&A”) expenses primarily consist of management salaries, professional fees, consulting fees, administrative fees, and general office expenses. G&A expenses increased by $2.6 million to $7.7 million in the nine months ended September 30, 2026, compared to $5.1 million in the comparable period in 2025. The increase was primarily due to severance expense related to the prior Chief Executive Officer, higher payroll expenses resulting from salary increases for existing employees, hiring of additional employees related to the Compute Services and Treasury Management segment, and increased stock-based compensation expense recognized during the nine months ended September 30, 2026.

 

35

 

 

Sales and marketing expenses. Sales and marketing expenses consist of expenses required to market and sell our products and services. Sales and marketing expenses increased by $1.8 million to $2.2 million in the nine months ended September 30, 2026, compared to $0.4 million in the comparable period in 2025. The increase was primarily due to increased sales and marketing activities to support the expansion of our compute services business.

 

Other income. We recognized other income of $0.5 million during the nine months ended September 30, 2026, compared to less than $0.1 million in the comparable period in 2025. Other income in 2026 consisted of income from the Aethir lending arrangement of $0.1 million and $0.3 million of dividend income.

 

Unrealized gain on equity securities and convertible note receivable. We recognized an unrealized gain of $4.6 million in the three and nine months ended September 30, 2026, reflecting the change in fair value of our investment in DataMeds common stock and the DataMeds convertible note receivable received as consideration for the sale of Helomics, from initial fair values of $0.6 million and $1.2 million, respectively, to $2.0 million and $4.3 million as of September 30, 2026.

 

Loss on derivative instruments. We recorded a loss on derivative instruments of $74.4 million in the three and nine months ended September 30, 2025, with no such loss in 2026.

 

Discontinued operations. Loss from discontinued operations, net of the gain on disposal of Helomics, was $2.1 million for the nine months ended September 30, 2026, consisting of a $2.5 million loss from Helomics’ operations through its September 11, 2026 sale, partially offset by a $0.4 million gain on disposal, compared to a loss of $2.3 million in the nine months ended September 30, 2025.

 

Liquidity and Capital Resources

 

Cash Flows

 

On September 30, 2026, we had $147.7 million in cash and cash equivalents. Cash and cash equivalents from continuing operations increased by $137.0 million from December 31, 2025, due to the following factors.

 

Net cash provided by operating activities of continuing operations was $465.2 million in the nine months ended September 30, 2026, compared to net cash used in operating activities of continuing operations of $3.4 million in the nine months ended September 30, 2025. The cash provided by operating activities in the 2026 period was driven primarily by a $569.2 million increase in contract liabilities reflecting customer prepayments for compute capacity, partially offset by $92.7 million of compute prepayments, $9.3 million of lease prepayments capitalized in right-of-use assets, $3.5 million of operating lease liability payments and a $1.0 million increase in accounts receivable. Our net loss from continuing operations of $11.3 million included non-cash net losses on digital assets of $6.9 million, partially offset by a non-cash unrealized gain of $4.6 million on equity securities and the convertible note receivable, which did not affect operating cash flows.

 

We used cash of $334.7 million in investing activities of continuing operations in the nine months ended September 30, 2026, consisting of $242.3 million to acquire property and equipment, primarily GPU infrastructure for our Build model contracts, $87.8 million for the acquisition of the Cluster, and a $4.6 million non-cash unrealized gain on equity securities and the convertible note receivable that is presented within investing activities in the condensed consolidated statements of cash flows. No cash was used in investing activities of continuing operations in the nine months ended September 30, 2025.

 

Net cash provided by financing activities of continuing operations was $10.4 million in the nine months ended September 30, 2026, compared to $4.6 million provided by financing activities of continuing operations in the nine months ended September 30, 2025. Cash provided by financing activities of continuing operations in the 2026 period was primarily related to net proceeds of $10.3 million from the issuance of common stock and warrants, including sales under our at-the-market offering program. Cash provided by financing activities of continuing operations in the 2025 period was primarily related to proceeds from the issuance of common stock and warrants.

 

Discontinued operations used cash of $4.0 million in the nine months ended September 30, 2026, consisting of $2.4 million used in operating activities and $1.6 million used in investing activities, which includes the $1.5 million cash payment to DataMeds at the closing of the Helomics sale, compared to $1.7 million used in the nine months ended September 30, 2025. The 2025 amount included $0.6 million of investing cash provided by the sale of Eagan assets pursuant to the asset purchase agreement executed with DeRoyal in March 2025.

 

Liquidity and Plan of Financing

 

Liquidity is a measure of our ability to access sufficient cash flows to meet the short-term and long-term cash requirements of our business operations. We have incurred significant and recurring losses from operations for the past several years. As of September 30, 2026, and December 31, 2025, we had cash and cash equivalents of $147.7 million and $10.8 million, respectively, and working capital of $51.1 million and $38.5 million, respectively, and accumulated deficit of $426.9 million and $413.5 million, respectively.

 

36

 

Our near-term liquidity requirements also include the deferred purchase price issued in connection with our September 30, 2026 acquisition of the SPV. The deferred purchase price has a face amount of $42.9 million, of which approximately $2.1 million is scheduled for payment in the remainder of 2026 and $40.8 million in 2027, including a payment of approximately $34.3 million of all remaining unpaid amounts due no later than September 30, 2027, or earlier if we or an affiliate enter into a financing secured by the Cluster. The obligation is secured by a security interest in the Cluster. Our cash and cash equivalents include customer prepayments received under compute contracts, which we expect to use to fund the purchase and deployment of the related infrastructure. See Notes 4, 7, 8 and 9 to the unaudited condensed consolidated financial statements.

 

To meet our short-term liquidity needs in the next twelve months, which are primarily comprised of working capital requirements, we have access to various sources of short-term liquidity including cash and cash equivalents and ATH tokens in our treasury. These include approximately 2.6 billion ATH tokens as of September 30, 2026, and an additional 1.6 billion ATH tokens expected to vest over the subsequent twelve-month period. Although we do not anticipate needing to use our ATH to meet our short-term liquidity needs, to the extent necessary, we may seek to use proceeds from the sale of our ATH to meet such needs. Additional sources of liquidity could include our ATM facility and the SEPA facility, subject to certain limitations and conditions associated with the respective facilities.

 

We consider the ATM facility to be a viable source of incremental liquidity during fiscal year 2026, subject to market conditions. We do not assume immediate or full utilization of the ATM facility in our base-case liquidity forecast. Rather, ATM proceeds are considered a discretionary funding source that could be accessed opportunistically during periods of sufficient market liquidity and pricing stability. Based on current market conditions, we believe that any ATM issuances, if undertaken, could occur in fiscal year 2026.

 

Additionally, the SEC declared effective our Form S-3 registration statement on July 20, 2026. The registration statement permits us to offer up to $1 billion of securities from time to time. No securities have been issued under the registration statement as of September 30, 2026; however, this registration statement allows for future financing flexibility.

 

Beyond the next twelve months, our long-term liquidity needs are primarily for obligations related to working capital requirements. Our ability to meet these needs and the adequacy of available funds depend on our ability to generate income from our compute services and treasury strategy, and the availability of future financing to fulfill our business plans. We will also have access to an additional 1.6 billion ATH tokens expected to be vested beyond twelve months from September 30, 2026.

 

We note that a significant portion of our liquidity is held in ATH, a digital asset, which has exhibited substantial price volatility over recent trailing 3-, 6-, and 9-month periods. We acknowledge that ATH prices are subject to rapid fluctuations due to factors including market sentiment, regulatory developments, network adoption, governance decisions of the Aethir Foundation, and broader crypto-asset market conditions.

 

We have considered downside price scenarios in which the market price of ATH declines materially over the 12-month period following the balance sheet date. Under these scenarios, the U.S. dollar value of our ATH holdings available for liquidity purposes would be reduced, which has the potential to pressure our ability to fund operating expenses.

 

We have incorporated these possible scenarios when determining our liquidity; however, we believe we have access to sufficient alternative liquidity sources, as noted above, to weather adverse ATH market price conditions.  

 

Financing Transactions 

 

We have primarily funded our operations through a combination of debt and equity instruments, and a variety of debt and equity offerings. We have no off-balance sheet transactions.

 

37

 

 

At The Market Offering

 

We maintain an ATM equity offering program pursuant to a Sales Agreement with Wainwright under which we may offer and sell shares of our common stock from time to time. In May 2026, we increased the capacity under the ATM program to an aggregate of $100.0 million. During the nine months ended September 30, 2026, we received approximately $10.3 million of net proceeds from sales under the ATM program with the most recent bringdown occurring on April 27, 2026. As of September 30, 2026, approximately $83.0 million remained available for future issuances under the program.

 

Standby Equity Purchase Agreement

 

In July 2025, we entered into a Standby Equity Purchase Agreement (“SEPA”) with YA II PN, Ltd. that provides us with the ability to sell up to $10.0 million of common stock from time to time, subject to the terms, conditions and limitations set forth in the agreement. The facility may provide an additional source of capital to support our operations and growth initiatives. As of September 30, 2026, we have not issued any shares or received any proceeds under the SEPA.

 

September 2025 Private Placements

 

In September 2025, we completed private placement transactions consisting of a cash PIPE financing that generated gross proceeds of approximately $50.8 million and a crypto-denominated PIPE transaction for ATH digital assets with a discounted value of approximately $173.3 million. The transactions provided significant capital to support our operational, strategic, and treasury initiatives.

 

Deferred Purchase Price

 

In connection with the acquisition of the SPV on September 30, 2026, we issued a deferred purchase price of $42.9 million, payable in 60 monthly installments of $715,000 in arrears, subject to mandatory acceleration: all remaining unpaid amounts are due on the earlier of September 30, 2027 and the date on which we or an affiliate enter into a loan or other financing secured by the Cluster. The deferred purchase price bears no stated interest. We recorded it at its present value of $36.6 million using an imputed interest rate of 17.71%, and we will recognize the $6.3 million discount as interest over the expected 12-month term. The obligation is secured by a security interest in the Cluster held by Duos Technologies until it is paid in full. See Note 1 and Note 8 to the unaudited condensed consolidated financial statements.

 

Critical Accounting Estimates

 

Management's discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements and the related notes thereto, which have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). In preparing the condensed consolidated financial statements, we apply accounting policies and estimates that affect the reported amounts and related disclosures. Inherent in such policies are certain key assumptions and estimates made by management, which we believe best reflect our underlying business and economic conditions. Our estimates are based on historical experience and various other factors and assumptions that we believe are reasonable under the circumstances. We regularly re-evaluate our estimates used in the preparation of the condensed consolidated financial statements based on our latest assessment of the current and projected business and economic environment. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty and actual results could differ materially from the amounts reported based on these estimates. There have been no material changes to our critical accounting policies and estimates as described in our Annual Report on Form 10-K for the year ended December 31, 2025, other than those noted below.

 

Incremental Borrowing Rates for Operating Leases and Deferred Purchase Price

 

Two of our measurements depend on estimating a rate at which we could borrow on a collateralized basis: operating lease liabilities, which use our incremental borrowing rate (“IBR”), and the non-interest-bearing deferred purchase price for the Cluster, which uses an imputed interest rate. Neither rate is observable. We have limited borrowing history and no rated debt, so each rate requires judgment including evaluating reference rates for secured borrowings, and adjusting for our credit profile, collateral and lease term via input from a third-party valuation provider.

 

Operating leases. Our compute leases do not provide an implicit rate, so lease liabilities are measured at the present value of fixed lease payments using the IBR at commencement. As of September 30, 2026, operating lease liabilities were $29.9 million, with a weighted average discount rate of 12.3% and a weighted average remaining term of 1.96 years (see Note 9). The IBR is set at commencement and is not updated unless the lease is modified. Its largest effect therefore falls on leases signed but not yet commenced, which have $407.4 million of future payments, are expected to commence in 2026 and 2027 and have terms of two to four years. A higher IBR lowers the initial lease liability and ROU asset and raises interest accretion over the term, and a lower IBR does the reverse. Total operating lease expense is generally straight-line and is not sensitive to the IBR, but the amounts recognized on the balance sheet are.

 

38

 

Deferred purchase price. In connection with the September 30, 2026, acquisition of the SPV, we issued a deferred purchase price (“DPP”) with a face amount of $42.9 million, payable in 60 monthly installments of $715,000, with all remaining amounts due on the earlier of September 30, 2027, and the date we or an affiliate enter into a financing secured by the Cluster. Because the obligation bears no stated interest, we recorded it at its present value of $36.6 million using an imputed rate of 17.71% and recorded the $6.3 million discount as a reduction of the liability, to be recognized as interest under the effective interest method. Because the Cluster was recorded as an asset acquisition, the present value is part of its $124.4 million cost, so the rate affects both the carrying amount of the Cluster and the amount of future interest expense. Measuring the DPP requires two estimates:

 

●

The imputed rate – we selected the rate we believe we could obtain for a similar financing secured by the Cluster, considering the collateral, the term, our credit profile and potential rates on comparable GPU-secured financings. A 100-basis point change in the rate would change the recorded present value, the discount and the cost of the Cluster by approximately $0.3 million.

 

●

The expected term – we assumed 12 months, reflecting the mandatory payment date of September 30, 2027. Repayment is accelerated if we enter into a financing secured by the Cluster. If we repay earlier, the unamortized discount would be recognized as interest sooner, and the initial discount would have been smaller.

 

Estimated Useful Lives of Property and Equipment

 

Property and equipment is depreciated on a straight-line basis over its estimated useful life. Technology equipment, principally GPU servers and related infrastructure, is depreciated over five to seven years. Useful lives are judgmental. They depend on expected technological obsolescence, the pace of new GPU generations, expected utilization, and the ability to redeploy equipment after the initial customer contract ends. Our customer contracts are generally shorter than the useful lives, so recovery of the asset’s carrying amount beyond the contract term depends on re-marketing the equipment.

 

As of September 30, 2026, property and equipment, net was $366.7 million, all of it construction in progress that had not been placed in service and is not yet depreciating. This includes $242.3 million of GPU infrastructure for Build model contracts and the $124.4 million Cluster acquired on September 30, 2026. Depreciation will begin when each asset is placed in service, and for the Build model equipment we expect that to start in the fourth quarter of 2026. We also expect to continue making substantial purchases of GPU infrastructure. For illustration, assuming no residual value and all construction in progress is placed in service, annual depreciation on the $366.7 million would be approximately $73.3 million at five years and $52.4 million at seven years. A one-year change in the estimated life within that range would change annual depreciation by approximately $9 million to $12 million. We review useful lives each reporting period and assess the equipment for impairment whenever events or changes in circumstances indicate the carrying amount may not be recoverable. A change in estimated useful life is accounted for prospectively. Accelerated obsolescence or an impairment charge could materially affect our results of operations.

 

Recent Accounting Developments

 

See “Recently Issued Accounting Pronouncements” under Note 2 - Summary of Significant Accounting Policies to the unaudited condensed consolidated financial statements of this Quarterly Report on Form 10-Q for further details.

 

39

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not required.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act), defines the term “disclosure controls and procedures” as those controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as of September 30, 2026. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were effective as of September 30, 2026.

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended September 30, 2026, the Company implemented new processes, controls, and procedures related to revenue recognition for compute services and for its digital asset and compute operations. These changes included enhancements to the Company’s policies, people, technologies, and operational processes designed to address the risks associated with digital asset activities as well as preventative and mitigating controls over the acquisition, custody, safeguarding, valuation, and financial reporting of digital assets.

 

As the Company continues to expand its digital asset and compute operations, management continues to enhance and refine certain processes and controls related to wallet management, custody arrangements, valuation methodologies, and related financial reporting activities in order to support the Company’s evolving operations and reporting requirements. Other than the changes described herein, there were no changes in the Company’s internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f)) during the quarter ended September 30, 2026, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

In the ordinary course of business, we may periodically become subject to legal proceedings and claims arising in connection with ongoing business activities from time to time. The results of litigation and claims cannot be predicted with certainty, and unfavorable resolutions are possible and could materially affect our results of operations, cash flows or financial position. In addition, regardless of the outcome, litigation could have an adverse impact on us because of defense costs, diversion of management attention and resources and other factors. 

 

Information regarding our legal proceedings can be found in Note 8, Commitments and Contingencies, to the unaudited condensed consolidated financial statements of this Quarterly Report on Form 10-Q.

 

ITEM 1A. RISK FACTORS

 

Except as set forth below, there have been no material changes to our risk factors from those disclosed under “Risk Factors” in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 31, 2026 (the “2025 Form 10-K”). On September 9, 2026, we filed a Current Report on Form 8-K furnishing supplemental risk factors that reflect our expansion into the purchase, ownership, and operation of GPU computing infrastructure deployed in data center facilities. The risk factors set forth below supplement and update the risk factors disclosed in the 2025 Form 10-K and should be read together with the risk factors and other information contained in the 2025 Form 10-K and our other filings with the SEC. To the extent the following is inconsistent with the risk factors in the 2025 Form 10-K, the following supersedes those risk factors. Any of the following risks could materially and adversely affect our business, financial condition, results of operations, and prospects, and the trading price of our common stock could decline. Additional risks and uncertainties not currently known to us or that we currently deem immaterial may also impair our business operations.

 

40

 

 

Risks Related to Our Ownership and Operation of GPU Computing Infrastructure

 

Our expansion into owning and operating GPU computing infrastructure is capital-intensive and will require substantial and growing capital expenditures, and any inability to obtain capital on acceptable terms may adversely affect our business.

 

We have historically pursued an asset-light operating model under which we did not own GPU computing hardware within physical data center facilities and instead provided access to GPU compute capacity primarily through infrastructure made available by the Aethir network. We have now expanded our business to purchase, own, and operate GPU computing hardware. This owned-asset model is substantially more capital-intensive than our prior model and will require significant and growing capital expenditures to procure, deploy, maintain, upgrade, and expand our infrastructure. We expect to fund these expenditures through a combination of customer deposits and prepayments, cash from operations, and equity and debt financing, which may not be available to us on favorable terms, or at all. If adequate financing is not available when required, we may be unable to acquire the hardware and infrastructure necessary to fulfill our customer commitments or execute our growth strategy. If we raise additional funds through equity or convertible securities, our existing stockholders may experience substantial dilution, and any such securities may have rights, preferences, and privileges senior to those of our common stock.

 

The GPUs and related infrastructure we will now own are subject to rapid technological obsolescence, and our results of operations depend on our ability to accurately estimate their useful lives and to avoid impairment of these assets.

 

Unlike our prior model, in which we did not own the underlying compute hardware, we now bear the full economic risk of the GPUs and related equipment we purchase. GPU technology is advancing rapidly, and newer generations of GPUs that offer materially better performance, efficiency, or total cost of ownership are introduced frequently. As a result, the GPUs and related infrastructure we will now own may become obsolete, decline in value, or generate lower pricing and utilization than we anticipate before the end of their expected useful lives. We must make estimates regarding the useful lives of our computing equipment and our ability to redeploy that equipment beyond the term of any initial customer contract, and we cannot guarantee that these estimates will prove accurate. If our assumptions regarding useful lives, residual values, redeployment, or utilization prove incorrect, or if events or changes in circumstances indicate that the carrying amount of our infrastructure may not be recoverable, we may be required to accelerate depreciation or record material impairment charges, which could materially and adversely affect our reported financial results.

 

A substantial portion of our compute revenue is expected to be derived from a limited number of customers and contracts, and the loss of, or non-performance by, any such customer would adversely affect our business.

 

We expect that, for the foreseeable future, a substantial portion of our compute revenue will be concentrated among a small number of customers and contracts. This concentration exposes us to heightened counterparty credit risk and to the risk of non-payment or non-performance, including in the event a customer experiences financial difficulty, insolvency, or bankruptcy. Although certain of our contracts are structured on a take-or-pay basis and secured with a deposit, prepayment, and monthly in-advance payments, we cannot assure you that a customer will perform its obligations, that the definitive agreements will be enforceable in accordance with their terms, or that a customer will exercise any renewal option. The loss of, a default by, a dispute with, or a significant reduction in spending by any one of our major customers, or our inability to replace such revenue on comparable terms, could have a disproportionate adverse effect on our business, results of operations, and financial condition.

 

Our Georgia AI cluster revenue depends on a single reseller, Duos, which also owns the facility and bears its power and colocation costs.

 

We do not contract directly with the ultimate user of our Georgia AI cluster. We provide capacity to Duos Edge AI, Inc. (“Duos”), which resells it to Meta 1 Network Group Limited (“Meta 1”). In October 2026, we terminated our direct master services agreement with Meta 1, and we no longer have a direct contractual relationship with Meta 1, so we have no direct recourse against Meta 1 for nonpayment or nonperformance and must rely on Duos to enforce its rights against Meta 1. Duos also owns and operates the facility in which the cluster is located and has agreed to bear colocation and energy costs for the five-year term. Duos is an affiliate of Duos Technologies Group, Inc. (“Duos Technologies”), the seller of the cluster and the holder of a security interest in it, as described below, so a single corporate group serves as our reseller, facility owner and operator, energy and colocation cost-bearer, and secured creditor with respect to the cluster. We therefore face concentrated credit and performance risk with respect to Duos and its affiliates and, indirectly, Meta 1 and its customers. If Duos experiences financial difficulty, breaches or terminates its agreements with us, fails to pay facility or power costs, or has a dispute with Meta 1, we could lose revenue, be required to bear facility and power costs directly, or be required to relocate the cluster, any of which could materially and adversely affect our business. Any dispute with Duos or its affiliates under one of these arrangements could also adversely affect our rights or relationships under the others.

 

Our compute business depends on the operation of dedicated data center facilities, including the availability of reliable power and cooling, and operational failures at these facilities could materially disrupt our ability to serve customers.

 

41

 

Our expanded business depends on deploying and operating owned GPU infrastructure within dedicated data center facilities. The performance, availability, and delivery of our services depend on numerous factors, many of which are outside our control, including the continued availability and functioning of power and cooling systems, the success or failure of redundancy, disaster recovery, and business continuity systems, and decisions or failures by the third-party owners and operators of the facilities in which our infrastructure is installed. Such data centers and associated infrastructure are also subject to risks of damage, interruption, or destruction from power outages, equipment failures, fires, floods, natural disasters, physical or cybersecurity attacks, human error, and other events. Because the deployment under our largest contract to date is concentrated in a single facility, any prolonged outage, capacity constraint, or other disruption affecting that facility could prevent us from meeting contracted service levels, expose us to service credits, penalties, or termination rights, and materially and adversely affect our business.

 

Our business could be harmed if we are unable to secure sufficient power, or by increases in the cost of power or the imposition of new regulatory requirements on data center power consumption.

 

Operating owned GPU infrastructure requires access to substantial, reliable, and cost-effective electrical power; our largest deployment to date requires approximately 5 megawatts of committed power capacity alone. The rapid expansion of AI and large-scale data center development has significantly increased electricity demand in certain markets, and policymakers, utilities, and regulators are increasingly scrutinizing the impact of data centers on ratepayers, grid reliability, and the environment. We may face power outages, shortages, capacity constraints, interconnection delays, or significant increases in the cost of securing power, any of which could limit our ability to operate or expand our infrastructure. In addition, governments may impose new requirements on data center operators, including obligations to fund grid upgrades, procure dedicated generation, enter into long-term capacity arrangements, accept curtailment during periods of grid stress, or satisfy additional permitting, carbon reporting, or cost-allocation requirements, and may restrict, condition, or delay new data center development. The global energy market has experienced significant volatility and inflationary pressure, and we expect power costs to remain volatile and unpredictable. Any of these developments could increase our operating costs, impair our ability to serve customers, delay our growth, and materially and adversely affect our business.

 

We depend on a limited number of suppliers, and primarily on NVIDIA, for the GPUs and other hardware we purchase, and any supply disruption, delay, or price increase could impair our ability to deploy infrastructure and fulfill customer commitments.

 

Our ability to acquire and deploy owned GPU infrastructure depends on our ability to procure GPUs and related hardware in sufficient quantities, on acceptable terms, and within timeframes consistent with our customer commitments. We source GPU hardware primarily from NVIDIA, which is currently the dominant supplier of GPUs used for AI training and inference, and we do not manufacture any hardware ourselves. Reliance on a limited number of suppliers exposes us to a range of risks, including limited availability of the latest-generation components, lack of control over production costs, delivery, and pricing, extended or unpredictable lead times, the potential for binding price or purchase commitments at above-market rates, supplier prioritization of other customers, and shifts in market-leading technologies away from those offered by our current suppliers. Our suppliers in turn rely on complex networks of third-party suppliers, including semiconductor foundries such as Taiwan Semiconductor Manufacturing Company, and any disruption affecting these upstream suppliers, whether due to geopolitical factors, capacity constraints, or natural disasters, could affect the availability and cost of the hardware we require. The loss of or significant disruption to our access to NVIDIA GPU supply and related hardware, any delay or failure in delivery under our purchase orders, any inability to fund our purchase commitments when due, or material price increases or extended delivery lead times, could delay our deployments, reduce our available capacity, and materially and adversely affect our business.

 

We may be unable to deploy our owned infrastructure on the timelines we have committed, and delays in deployment could result in penalties, lost revenue, or reputational harm.

 

Our largest contract to date contemplates a dedicated cluster purpose-built to the customer's specifications, with a targeted deployment start in the fourth quarter of 2026. The procurement, integration, configuration, and commissioning of large-scale GPU clusters and associated storage, networking, power, and cooling infrastructure is complex and subject to numerous potential points of failure, including hardware delivery delays, facility readiness, the availability of data center equipment such as switchgear, power distribution units, and cooling equipment, the availability of skilled labor, and dependence on third-party facility operators and contractors. Our forward-looking statements regarding deployment are subject to risks relating to the execution and enforceability of the definitive agreement, hardware supply chain constraints, and facility readiness. If we are unable to deploy contracted infrastructure on the agreed schedule, we may be subject to service credits, penalties, delayed or reduced revenue, customer disputes, termination rights, or reputational harm, any of which could materially and adversely affect our business.

 

If customer demand is insufficient to utilize the capacity we build, or if we are unable to redeploy infrastructure following the expiration or termination of a contract, we may not realize the expected returns on our capital investments.

 

The owned-asset model requires us to commit substantial capital to acquire and deploy infrastructure, often in advance of, or in reliance upon, specific customer contracts. Our expected returns depend on sustained customer demand and high utilization of the capacity we build. If a customer reduces its usage, does not renew or terminates its contract, or if we are otherwise unable to redeploy or resell capacity on economically attractive terms following the expiration of an initial contract term, we may experience underutilized capacity, stranded assets, reduced margins, or impairment charges. Because our infrastructure is purpose-built and concentrated, and because GPUs are subject to rapid obsolescence, we may be unable to repurpose assets for other customers or workloads without incurring additional cost or delay. Any failure to achieve sufficient utilization of our owned infrastructure could materially and adversely affect our business, results of operations, and financial condition.

 

42

 

We expect to incur indebtedness and to use secured or asset-backed financing structures to fund our infrastructure, and our leverage could adversely affect our financial condition and flexibility.

 

To fund the acquisition of GPU infrastructure, we may incur substantial indebtedness and may pursue secured financing arrangements, including asset-backed, equipment-financing, or other collateralized structures, in which our GPUs and related assets serve as collateral. Companies in our industry carry significant indebtedness and finance GPU purchases through delayed draw term loans, original equipment manufacturer financing arrangements, and similar structures secured by the depreciable cost of GPU servers. A substantial level of indebtedness could require us to dedicate a significant portion of our cash flow to debt service, increase our vulnerability to adverse economic and industry conditions, limit our ability to obtain additional financing, restrict our operational and strategic flexibility through restrictive covenants, and expose us to the risk of acceleration or foreclosure on pledged assets in the event of a default. The management of a more complex capital structure, including multiple layers of secured and unsecured debt with differing covenants, maturities, and priorities, could increase our financial and operational risks and heighten the risk of disputes among creditors. Rising or volatile interest rates would increase the cost of any floating-rate indebtedness, and we may be required to enter into interest rate hedging arrangements that may not be effective.

 

We owe a substantial deferred purchase price for our Georgia AI cluster, secured by the cluster, and may be unable to pay or refinance it when due.

 

In connection with our September 30, 2026 acquisition of the SPV, we agreed to pay Duos Technologies Group, Inc. a deferred purchase price of $42.9 million in monthly installments of $715,000, with any unpaid balance due in full by the earlier of twelve months after signing and the date we enter into a financing secured by the cluster. Duos Technologies holds a security interest in the cluster securing the deferred purchase price until it is paid in full. Because the monthly installments alone would not retire the balance before it matures, we expect to need to refinance a substantial portion of the deferred purchase price. If we are unable to obtain refinancing on acceptable terms, or at all, before the balance comes due, we may default, and Duos Technologies could foreclose on the cluster, which generates substantially all of our owned-infrastructure revenue. Because the balance accelerates upon any cluster-secured financing, the deferred purchase price may also reduce the net proceeds available to us from any such financing.

 

We may not realize the anticipated benefits of our acquisition of the Georgia AI cluster or any future acquisitions, and acquisitions may expose us to unknown liabilities.

 

On September 30, 2026, we acquired the SPV, which owns our Georgia AI cluster, and we may pursue additional acquisitions of GPU infrastructure or related businesses. We may not realize the revenue, utilization, or other benefits we expect from these acquisitions, including if the customer arrangements for the acquired cluster do not perform as anticipated. Acquisitions involve risks, including difficulties integrating acquired assets, operations, personnel, and systems; diversion of management attention; reliance on representations, warranties, and indemnities from sellers that may be limited or unenforceable; and exposure to liabilities of the acquired business that were unknown or greater than anticipated. Acquisitions may also require us to incur indebtedness or other deferred payment obligations, issue equity securities that dilute our stockholders, or record impairment of goodwill or other acquired assets, any of which could materially and adversely affect our business, financial condition, and results of operations.

 

We have a limited operating history operating an owned-infrastructure GPU business, which makes it difficult to evaluate our business and prospects.

 

We have only recently expanded into purchasing, owning, and operating GPU computing infrastructure, and we have a limited operating history under this business model. Our prior compute model was asset-light and distributed, and the owned-infrastructure model requires different capabilities, including the procurement and lifecycle management of hardware, the operation of dedicated data center deployments, the management of large multi-year take-or-pay contracts, and the management of capital-intensive financing. Our limited experience delivering and managing longer-term, large-scale customer contracts may expose us to cost overruns, underutilized capacity, performance obligations, service-level commitments, and other contractual liabilities. As a result, our historical results are not indicative of our future performance, our future results may be difficult to predict and may fluctuate significantly from period to period, and you should consider our business and prospects in light of the risks and uncertainties frequently encountered by companies operating in new and rapidly evolving capital-intensive markets.

 

The energy and environmental demands of data centers and GPU compute infrastructure may constrain the growth of the compute market and result in increased regulatory costs or operational limitations.

 

Data centers are significant consumers of electrical power, and this level of energy consumption has attracted increasing scrutiny from regulators, utilities, and environmental groups, which may result in additional restrictions, permitting requirements, carbon reporting obligations, or energy surcharges that increase the cost of GPU compute infrastructure. Because we will now own and operate GPU computing infrastructure deployed in dedicated data center facilities that require substantial committed power, including approximately 5 megawatts of dedicated power for our largest deployment to date, constraints on available power capacity, increases in the cost of power, and new regulatory or environmental requirements directly affect our operating costs and our ability to expand. In addition, reputational and environmental, social, and governance concerns relating to the energy and water footprint of AI compute infrastructure could adversely affect our business relationships, our access to capital, and our ability to obtain permits and approvals.

 

43

 

Geopolitical tensions and trade restrictions, particularly between the United States and China, could disrupt GPU supply chains and limit our addressable market.

 

The global GPU compute market depends heavily on complex international supply chains, including semiconductor manufacturing concentrated in Taiwan and South Korea, and geopolitical tensions between the United States and China have already resulted in restrictions on the export of certain advanced semiconductors, including certain NVIDIA GPU products. Because we will now own GPU hardware sourced primarily from NVIDIA, geopolitical tensions, tariffs, economic sanctions, and export controls directly affect the cost, availability, and delivery lead times of the GPUs and related components we acquire. Increasing use of tariffs and export controls has impacted, and may in the future impact, the availability and cost of GPUs and other components, and expansion or reinterpretation of U.S. export controls covering advanced computing hardware could limit the availability of components or require reconfiguration of our deployment plans. Any such disruption could increase our procurement costs, delay our deployments, and materially and adversely affect our compute business and our ability to execute our strategy.

 

Demand for GPU compute is highly concentrated, and a slowdown in AI-related spending or the development of excess industry capacity could adversely affect our business.

 

A substantial portion of current and projected demand for GPU compute infrastructure is driven by a small number of large technology companies and government-sponsored AI programs, and any significant reduction in their capital expenditures could have a disproportionately negative impact on the broader GPU compute market. In addition, a substantial portion of our own compute revenue is now expected to be derived from a limited number of customers and contracts, including our thirty-six-month enterprise engagement of approximately $260 million announced in April 2026 and the customer agreements for our Georgia AI cluster, from which we expect to generate approximately $364.6 million in revenue over their term. A slowdown, deferral, or reprioritization of AI-related customer spending, or the development of excess industry capacity if anticipated AI workloads do not materialize, could result in pricing pressure, reduced utilization, longer sales cycles, contract renegotiations, or impairment charges, any of which could be magnified by the capital-intensive, owned-asset nature of our expanded business.

 

Advances in AI model efficiency could reduce demand for GPU compute, adversely affecting the value of our compute business and our owned infrastructure.

 

A key driver of demand for GPU compute is the scale required to train and run AI models, and consistent advances in AI model efficiency — such as new architectures, training techniques, or algorithmic improvements that achieve equivalent or superior results using significantly less compute — could substantially reduce demand for raw GPU compute capacity. Because we will own GPU hardware rather than relying solely on a distributed network, a significant and sustained reduction in GPU compute demand could reduce the utilization, pricing, and resale or redeployment value of our owned infrastructure, and could require us to recognize accelerated depreciation or impairment charges, in addition to adversely affecting the value of our ATH treasury holdings.

 

Security breaches and other disruptions affecting our infrastructure or the facilities in which it is housed could compromise sensitive information and expose us to liability.

 

Our business requires that we collect and store sensitive data, and our information technology and infrastructure are susceptible to attacks by hackers, viruses, employee error, malfeasance, or other activities. In addition, our owned GPU computing infrastructure and the data center facilities in which it is deployed are subject to physical and cybersecurity risks, including attacks by outside parties (whether private or state-backed), human error, malfeasance, insider threats, system vulnerabilities, and inadequate security controls, any of which could result in service outages, unauthorized access to or loss of customer data and workloads, or damage to our infrastructure. Our enterprise customers contract for dedicated infrastructure in part to ensure that their proprietary data remains within a controlled facility boundary, and any physical or cybersecurity incident affecting our infrastructure or the facilities in which it is housed could expose us to service-level penalties, contractual liability, loss of customers, regulatory exposure, and reputational harm.  

 

If our information technology and communications systems, or the infrastructure and facilities on which our compute business depends, fail or experience a significant interruption, our business could be materially and adversely affected.

 

The efficient operation of our business is dependent on information technology and communications systems, the failure of which could disrupt our business and result in decreased revenue and increased overhead costs. Our expanded business further depends on the continuous operation of owned GPU computing infrastructure housed in third-party data center facilities, and the availability and performance of that infrastructure depend on power, cooling, network connectivity, redundancy systems (including N+1 redundant power), and the performance of the third-party operators of the facilities in which our equipment is installed. The failure of any of these systems or services, including any failure of redundancy or disaster recovery measures, could prevent us from meeting contracted service levels and could materially and adversely affect our reputation, business, and results of operations.

 

44

 

Our expansion into owned GPU infrastructure has materially increased our capital requirements and our dependence on external financing.

 

We have a history of negative operating cash flows and have funded our operations in part through at-the-market and private placement equity financings, with a significant portion of our liquidity held in ATH, a digital asset whose market price has exhibited substantial volatility. Our expansion into purchasing and owning GPU computing infrastructure has materially increased our capital expenditure requirements and our dependence on external financing, and our liquidity needs are now driven in part by the substantial upfront and ongoing costs of acquiring, deploying, maintaining, and expanding owned hardware and data center capacity. Although certain of our contracts are supported by customer deposits, prepayments, and monthly in-advance payments on a take-or-pay basis, these amounts may be insufficient to fund our capital requirements, and our reliance on volatile sources of liquidity, including the price of ATH, may further constrain our ability to fund these commitments.

 

 

 

 

 

 

 

 

 

 

 

45

 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the three months ended September 30, 2026, there were no unregistered sales of securities that were not reported on a Current Report on Form 8-K.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

 

ITEM 5. OTHER INFORMATION

 

Not applicable.

 

 

ITEM 6. EXHIBITS

 

Exhibit Number

Description

2.1+

Equity Purchase Agreement, dated September 30, 2026, by and between the Company and Duos Technologies Group, Inc., relating to Duos Edge AI – GPUaaS, LLC.

2.2+

Stock Purchase Agreement, dated as of September 11, 2026, by and between DataMeds AI, Inc. and Axe Compute Inc. (filed on September 17, 2026 as an exhibit to our Current Report on Form 8-K and incorporated herein by reference).

31.1*

Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*

Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1**

Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS*

Inline XBRL Instance Document

101.SCH*

Inline XBRL Taxonomy Extension Schema Document

101.CAL*

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE*

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104*

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* Filed herewith

** Furnished herewith

+ Schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request. 

 

46

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

AXE COMPUTE INC.

 
     

Date: November 17, 2026

By:

/s/ Christopher Miglino

 
   

Christopher Miglino

 
   

Chief Executive Officer

 

 

Date: November 17, 2026

By:

/s/ Jeremy Yaukey-Witter

 
   

Jeremy Yaukey-Witter

 
   

Chief Financial Officer

 

 

 

 

 

47

Keep reading